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This project is a cross-sectional exploration of the psychological challenges 
experienced by young adults (YAs), age 15 to 39, with cancer in Canada and includes two 
published studies. YAs with cancer across the country completed an extensive online 
survey, which collected demographic information, cancer history, and included 
psychometric measures of psychological distress, fear of cancer recurrence (FCR), body 
image, sleep, well-being, posttraumatic growth and social support. Responses from 508 
participants diagnosed with cancer in young adulthood were collected to answer the 
research questions across the two studies, but the number of participants included in each 
analysis varies based on completion of outcome measures and matching characteristics. 
Participant responses from 448 YAs were used to explore whether high 
psychological distress reported by YAs with cancer is driven by developmental stressors 
shared by YAs generally, or represents the intersection of cancer and development 
stressors. An equal number of participants who completed the same distress measure were 
randomly sampled from the national Canadian Community Health Survey (2012) to 
create a non-cancer comparison group matched on age, sex and education. YAs with 
cancer reported significantly greater levels of distress, were less likely to be living 
independently, and less likely to report annual incomes greater than $40,000. Individual 
factors associated with experiencing high levels of distress included not working, body 
image dissatisfaction, poor social support and high FCR. Higher levels of education were 
a protective factor and associated with decreased likelihood of experiencing high distress. 
To better understand FCR in YAs with cancer, the responses of 461 participants 
were utilized to assess prevalence within this population. The prevalence of clinical levels 
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of FCR for YAs with cancer in Canada was 59%, and an additional 25% reported 
problematic levels. Individuals with a previous recurrence, distress, and body image 
dissatisfaction were more likely to experience clinical FCR, while those diagnosed with 
cancer five or more years ago were less likely.  
The pervasive nature of mental health challenges for YAs with cancer emphasizes 
how essential psychological support is for this population. Comprehensive, holistic and 
YA-specific programs are needed to address the developmental needs of YAs with cancer 
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Chapter 1: Why Cancer is Different for Young Adults: Using Patient-Oriented 




This thesis is a population investigation, including two different studies that 
explore the psychological consequences of cancer in young adulthood within a national 
sample of individuals diagnosed with cancer between ages 15-39 that reside in Canada. 
The first chapter will provide an overview of the literature that illustrates the theoretical 
motivation for these studies. This chapter begins with a brief explanation of the 
development and evolution of psycho-oncology, the added developmental challenges 
associated with a cancer diagnosis in young adulthood, the relationship between cancer 
and mental health, and how to apply patient-oriented research and knowledge translation 
to young adult (YA) cancer research. The first chapter concludes with a summary and the 
research objectives. Study 1 explores whether a cancer diagnosis contributes to greater 
psychological distress during young adulthood through comparison to matched peers. It 
also identifies factors associated with higher distress in young adults with cancer. Study 2 
examines the prevalence of fear of cancer recurrence, a cancer-specific psychological 
outcome, and the factors associated with clinical presentations of fear of cancer 
recurrence for young adults. The final chapter will contextualize these findings within the 
existing literature and explore implications for clinical practice to better meet the needs of 
young adults with cancer. Directions for future research are also outlined that emphasize 
patient perspectives in the development of interventions and in exploring the relationships 
among the key psychosocial concerns reported by YAs with cancer in Canada. 
1.2 The Development of Psycho-Oncology 
In the 19th century, there was little knowledge surrounding cancer's cause, 
treatment, and pain management; consequently, a diagnosis associated with substantial 
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social stigma and patients were rarely informed of the diagnosis (Holland & Rowland, 
1989). Advancements in knowledge and treatment contributed to significant 
improvements in patient outcomes, which coincided with transitions in early psychiatric 
philosophy, and the integration of psychiatric services into hospital settings (Watson et 
al., 2014). The 1950s represented a significant shift in psycho-oncology development by 
establishing the first psychiatric and clinical research group within a cancer centre and the 
emergence of self-help and patient support groups (Holland & Rowland, 1989).  
The growing role of psycho-oncology internationally in the 1990s prompted the 
development of treatment guidelines, measures to quantify patient's reported 
psychological symptoms and determine contributing factors, and specific language to 
describe the psychosocial impact of cancer (Holland, 2004; Watson et al., 2014). The 
term distress was selected to capture the experience of collective unpleasant or painful 
psychosocial responses that impair effective coping with cancer (Watson et al., 2014). 
Psychological distress can present as depression, anxiety, somatic symptoms, impaired 
relationships, and existential concerns (Howell & Olsen, 2011). Distress is now 
recognized as a the sixth vital sign alongside the other vital signs of respiration, 
temperature, heart rate, blood pressure, and pain (Bultz & Carlson, 2005). These 
developments occurred adjacent to advancements in behavioural research supporting 
modification of lifestyle factors to improve health outcomes and increased cancer 
prevention education (Breitbart & Alici, 2009). 
The development of psychosocial oncology has had a drastic impact on both the 
quality and cost of medical care (Carlson & Bultz, 2003). In determining the specific 
impact of psychosocial symptoms on healthcare, research has illustrated increased fatigue 
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and distress relates to increased medical spending (Carlson & Bultz, 2003). Lebel and 
colleagues explored the relationship between healthcare utilization and fear of cancer 
recurrence (FCR) in breast cancer survivors (n=231) (Lebel, Tomei, et al., 2013). Using 
the Fear of Cancer Recurrence Inventory and the Healthcare Utilization Questionnaire, 
they demonstrated that within six months, participants with high FCR, when controlling 
for demographic factors, had increased outpatient and emergency room visits, indicating 
higher healthcare costs.  
Conversely, psychosocial interventions can reduce psychiatric symptom burden, 
improve mood disturbances, and reduce pain, healthcare utilization and medical costs 
(Carlson & Bultz, 2004). In Simpson and colleagues' six-week cognitive/behavioural 
group intervention designed to improve psychological functioning adjustment to cancer, 
the intervention resulted in a 23.5% reduction in medical billing and improvements in 
psychological symptoms and well-being (Simpson et al., 2001). Participants were not 
selected based on the severity of distress symptoms; therefore, this likely underestimates 
the economic benefits of a psychosocial intervention for participants who have more 
severe distress (Carlson & Bultz, 2003). A systematic cost-analysis of 12 studies 
examining individual and group-based psychosocial interventions concluded that 
psychosocial interventions are cost-effective within cancer healthcare (Dieng et al., 
2016).   
Variability in screening and psychosocial interventions limits the generalization of 
effectiveness studies, yet research using systematic screening methods for distress and 
subsequent psychological interventions has demonstrated positive outcomes for reducing 
significant distress (Shimizu, 2013). Additionally, an early meta-analysis of randomized 
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controlled trials (n=62) examining the impacts of psychosocial interventions for adults 
with cancer, comparing patients receiving psychosocial services to individuals completing 
control tasks or not participating in interventions, revealed significant, small effect sizes 
across psychosocial domains (Meyer, 1995). Overall, patients engaging in interventions 
reported improved emotional adjustment outcomes, functional adjustment, disease-related 
symptoms, and global measures related to many categories, providing insights into the 
practical value of psychosocial interventions within this population. 
The above research illustrates the clinical and economic value of psychosocial 
care. However, research has largely failed to capture the experience and impact of a 
cancer diagnosis in young adulthood, a particularly vulnerable developmental period. 
1.3 The Impact of Cancer in Young Adulthood 
 
YAs make up a distinct population within the broader cancer care community. 
YAs with cancer are defined as individuals diagnosed with cancer between ages 15 and 
39 (Adolescent and Young Adult Oncology Progress Review Group, 2006; Aubin et al., 
2011). Individuals belonging to this population share similar physiological and biological 
characteristics, including hormonal maturity, unique tumour development, delays in 
receiving a diagnosis as YAs are often assumed to be "healthy," leading to 
underrepresentation in clinical trials (Bleyer, 2005). A cancer diagnosis in young 
adulthood can disrupt typical development resulting in significant psychological, 
developmental, social changes. YAs with cancer report higher levels of unmet 
psychological support needs, deficient care-seeking patterns, and lower adherence to 
recommended treatment and follow-up care, which have been linked to worse disease 
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outcomes (Galan et al., 2017). Due to the age and life stage at diagnosis, YAs face 
different psychosocial vulnerabilities related to their physical health and well-being (Park 
et al., 2014).  
Identity and Relationship Development 
Young adulthood is mired with psychosocial developmental tasks and includes an 
emphasis on transition, autonomy, and individual identity (Zirkel & Cantor, 1990). 
Developing autonomy within parental relationships is an essential part of identity and 
relational development in young adulthood (Fullinwider-Bush & Jacobvitz, 1993). Stable 
individual characteristics, including socioeconomic status, gender, and race/ethnicity, 
may be the basis for identity development; however, these factors are also influenced by 
physiological development/maturation, familial culture, and psychological functioning 
(Benson & Elder, 2011). Interpersonal relationships are often altered for YAs with 
cancer, including an increased reliance on others (Siegel et al., 1999). Changes often 
contribute to feeling socially isolated and managing others' emotional responses to the 
cancer diagnosis (D'Agostino & Edelstein, 2013). Research using collateral familial 
information to examine the social outcomes of YA brain tumour survivors (n=19) 
identified themes of poor social adjustment, withdrawal, poor social processing and 
communication (Wilford, 2017). The relationships of individuals with cancer and their 
partners are among the most negatively impacted life domains reported by YAs with 
cancer (Bellizzi et al., 2012). A systematic review examining the impact of cancer on 
romantic relationships for YA cancer survivors (n=21) identified distinct relationship 
challenges related to cancer diagnosis (Rabin, 2019). These concerns include how and 
when to disclose of cancer history and the content of this disclosure, regardless of 
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individual demographic characteristics of sexuality, gender, race and ethnicity. This 
review also suggests that YAs with cancer are more likely to experience delays in 
developing relationships, getting married, having children, and experiencing more 
adverse emotional responses when these relationships end. 
Family formation, the transition to parenthood, and subsequent changes in 
relationships are also fundamental developmental tasks of young adulthood (Committee 
on Improving the Health, 2015). Survivors who experience disruption in these areas are 
more likely to report impaired psychosocial functioning long into survivorship. A 
systematic review of the literature (n=47) examining the prevalence of fertility-related 
distress for survivors (Logan et al., 2019), reported increased rates of mental health 
symptoms, including depression, anxiety and trauma at diagnosis and during early 
treatment phases while accessing fertility preservation and compounding distress related 
to diagnosis. Further, female survivors without biological children before diagnosis may 
be particularly vulnerable to adverse mental health, and more significant overall distress. 
Canada and Schover examined the impact of cancer-infertility on long-term well-being 
for women diagnosed with cancer in young adulthood (Canada & Schover, 2012). 
Assessments of overall physical and mental health, psychological symptoms, the impact 
of cancer and reproductive concerns were completed with 240 women who had been 
diagnosed approximately 10 years prior. Distress reported by this sample was highest 
among women without children. Those who were unable to conceive were more 
distressed, had more intrusive thoughts, and used more avoidance coping with infertility. 
Cancer-related infertility in young adulthood is a lasting consequence of cancer, 
permanently altering patients' lives and contributing to long-term psychosocial impacts.  
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Patients may also experience distress and impairments in quality-of-life and 
mental health symptoms with worry about the impact of health on family functioning 
(Park et al., 2017; Park et al., 2016; Park et al., 2019). Qualitative research with young 
and middle-aged adults (Age: M = 44.2, SD = 9.0) with cancer (n=42), with children 
younger than 18 years old, reported prevalent concerns relating to the impact of their 
illness and death on families, cancer as a barrier to life experiences and typical 
responsibilities, and how the role of being a parent influenced treatment decision-making 
(Park et al., 2017). In a similar study, Park and colleagues examined parenting concerns, 
quality of life and distress in a sample of patients (n=63) diagnosed with stage IV cancer 
(Park et al., 2016). Researchers found that greater parenting concerns were significantly 
related to higher levels of depression and anxiety and reduced quality-of-life. The 
relationship between parenting concerns and mental health symptoms within this 
population suggests that disruption of developmental objectives (i.e., parenting) may 
influence the relationship between cancer diagnosis in young adulthood and impaired 
psychological functioning. 
Education and Occupational Development and Financial Consequences 
Beyond relationship-related developmental factors, young adulthood is also 
crucial for initiating careers and making decisions relating to life planning and 
establishing professional identities (Konstam, 2015). A cancer diagnosis can have 
significant negative financial consequences with increased medical expenses and 
disruptions to productivity during this time. Comparing financial indices between 
individuals diagnosed with cancer in young adulthood (n=575) and age, sex and 
education-matched peers (n=575), Mahon and colleagues demonstrated that survivors do 
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not recover financially from the disruptive impact of cancer during this vulnerable period 
(Mahon et al., In Press 2020). Specifically, YAs were more likely to report debt and 
fewer assets than non-cancer peers with differences maintained in middle-aged 
participants. Using data from the Medical Expenditure Panel Surveys (2008-2011) in the 
US, Guy and colleagues compared the direct medical costs, employment disability, and 
missed work between 1,464 YAs with cancer and 86,865 participants without cancer 
(Guy et al., 2014). Compared to non-cancer peers, YAs with cancer reported $3,170 
greater in medical expenses and $2,250 in productivity losses annually. Overall, YA 
cancer survivors were less likely to be employed and more likely to report limited 
financial resources. These findings are consistent with a meta-analysis created by de Boer 
and colleagues, which pooled the results of 36 international studies comparing 
employment rates between adults (age 18 to 60) with control participants (de Boer et al., 
2009). The overall pooled relative risk of unemployment was 33.8% for adults with 
cancer, compared to 15.2% for healthy adult controls. Long-term financial consequences 
of cancer can compound the disparities experienced by YA cancer survivors, making it 
increasingly challenging to address this population's identity and relationship concerns. 
Unemployment reflects difficulties and barriers associated with return-to-work for 
YAs with cancer. Parsons and colleagues used cross-sectional national data from the 
AYA HOPE study in the US to examine return-to-work within a sample of YAs (n=388) 
(Parsons et al., 2012). This study demonstrated that 72% of YA cancer survivors who 
engaged in full-time work or school before diagnosis returned to work, compared to a 
national average of roughly 80% for this population (Parsons et al., 2012). Being 
uninsured or quitting work after diagnosis was associated with a decreased likelihood of 
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returning to work and may contribute to unemployment rates more broadly among YAs. 
Additionally, participants were more likely to believe that cancer negatively impacted 
their career or educational plans if they had received physically intensive treatment or had 
left their jobs or schooling. 
YAs who return to work or schooling may still experience lasting impacts of their 
cancer treatment and report subjective cognitive impairments that impact occupational 
functioning (Parsons et al., 2012). In a study comparing YAs with cancer (n=23) to 
matched peers (n=14), survivors performed poorer on vigilance, processing, and 
attention-based tasks (Nugent et al., 2018). Small to medium effect sizes were also 
reported for worse perceived total cognitive functioning, including memory, executive 
function, language, orientation to place and time, and sensorimotor ability, suggesting 
survivors may experience further impairments if returning to work. Using semi-structured 
interviews Elsbernd and colleagues interviewed YAs (n=9) diagnosed with cancer while 
attending school to identify salient themes regarding transition back into their education 
(Elsbernd et al., 2018). Participants reported misunderstanding and lack of empathy from 
peers and physiological treatment symptoms as barriers experienced by YAs trying to 
return to school. 
The impact of cancer extends beyond occupational engagement, contributing to 
changes and subsequent challenges related to satisfaction and career development. In an 
ethnographic study, Rasmussen and Elverdam used observational and interview data from 
23 cancer-free survivors who had completed a week-long residential rehabilitation 
program addressing physical health and psychosocial well-being (Rasmussen & 
Elverdam, 2008). Interviews were conducted immediately after completion of the 
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program and 18 months later. Three central themes were identified by participants across 
both time points, including the disruption of their work lives, re-entry into work, and life 
without work. Experiences shared by participants suggests that individuals who are not 
able to return to work may experience grief related to identity loss, and consequently need 
to determine new areas of their lives to derive satisfaction and achievement. In a similar 
qualitative study with 13 YA women working full-time when diagnosed with breast 
cancer, participants identified workplace challenges related to cancer (Raque-Bogdan et 
al., 2015). Challenges included the need to re-examine career paths, with increased 
importance regarding balance, engaging in more value congruent work, and changes in 
ambition. These factors may contribute to further delays in return-to-work due to 
exploring alternative options that contribute to motivation, reflect changes in values or 
impact satisfaction. Consequently, YAs with cancer who tolerate treatment and manage 
physical and psychological symptoms continue to be at risk of disruptions to psychosocial 
functioning. Barriers to reintegration into the workforce have considerable financial 
implications for YAs with cancer and can pose further difficulties with autonomy, family 
planning and asset acquirement, illustrating how occupational disruption can pose further 
challenges. 
Existential distress 
YAs with cancer may also experience existential anguish through confronting 
their mortality (Siegel et al., 1999). Odh and colleagues evaluated the existential 
challenges reported by YAs with cancer in Sweden using an analysis of six blogs written 
by YA patients (Odh et al., 2016). Participants' blogs identified four themes: (1) 
existential thoughts on death, including the disruptive impact of cancer on plans; (2) 
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uncertainty; (3) trying to engage in their pre-cancer lives; and (4) meaning-making. 
Qualitative research confronting existential concerns has meaningful consequences for 
YAs ability to cope with everyday stressors and work towards long-term goals (Benton et 
al., 2014). Utilizing patient perspectives to inform treatment and services (Ngwenya et al., 
2017), and guide psychosocial interventions (Gagnon et al., 2015), are likely to be more 
effective at meeting needs to reduce existential distress for YAs. While qualitive studies 
are valuable, it is also important to note that the studies describing thematic issues for 
YAs with cancer often include very small sample sizes (Odh et al., 2016; Raque-Bogdan 
et al., 2015), which limits the application to the broader YA population. Larger 
population studies that explore and complement these themes would be beneficial in 
assisting with generalizability of the findings. 
YAs coping with cancer experience the same grief and fear related to diagnosis, 
pain and discomfort, and distress as other survivors across the lifespan; however, these 
experiences are exacerbated by the different developmental demands associated with 
young adulthood. Disruptions to identity development, relationship formation, 
educational attainment, financial security and difficulties processing existential crises at 
best leave YAs fighting to achieve the same milestones as same-aged peers or, worse, 
have the trajectories of their lives permanently altered. To address gaps in current 
healthcare, YAs with cancer require tailored research and interventions to address their 
needs as a distinct population within cancer care.  
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1.4 Cancer and Mental Health in Young Adults 
The bidirectional relationship between physical and mental health persists across 
the lifespan (Ohrnberger et al., 2017; Steinmo et al., 2014) and there has been growing 
academic advocacy for mental health research within oncology (Martinez, 2017; 
Niedzwiedz et al., 2019). The prevalence of adolescent and young adulthood mental 
health disorders has been well documented worldwide, with prevalence rates ranging 
from 8-57% in population studies (Patel et al., 2007). The prevalence rates for adolescents 
and YAs vastly exceed those reported in global epidemiological studies measuring 12-
month prevalence rates of anxiety, anxiety-related, and mood disorders (Bandelow & 
Michaelis, 2015; Hasin et al., 2018; Kessler et al., 2005; Ruscio et al., 2017). YA mental 
health vulnerability is similarly reflected in psycho-oncology (Lang et al., 2015; 
McDonnell et al., 2015; Park & Rosenstein, 2015; Stava et al., 2006). Examining diverse 
samples of cancer patients, younger participants, classified as those less than 50 years old, 
report higher prevalence rates of depression and anxiety across cancer diagnoses (Linden 
et al., 2012). Moreover, in large, heterogeneous samples of adults with cancer, younger 
age has been identified as a risk factor for experiencing trauma related to cancer (Abbey 
et al., 2015; Nipp et al., 2018). YAs may be particularly vulnerable to mental health 
symptoms. The developmental stressors associated with this stage of life also overlap 
with the age of onset of anxiety and mood disorders most commonly occurring during late 
adolescence and young adulthood (Kessler et al., 2007). 
In Australia, investigators utilized the Cancer Survival Study cross-sectional data 
to examine quality-of-life, health behaviours, and psychological well-being in a sample of 
YAs (n=58) six months after diagnosis (Hall et al., 2012). Outcomes were measured using 
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the European Organization for Research and Treatment of Cancer Quality of Life 
Questionnaire, version 3 (EORTC QLQ-C30), and Supportive Care Needs Survey-Short 
Form (SCNS-SF34), in addition to questions regarding health behaviours. Responses by 
YAs with cancer were compared to general population data for YAs nationally to 
contextualize the outcomes, and adults with cancer 64 years or older who had also 
completed the Cancer Survival Study. YAs who were six months post-diagnosis noted 
significant impairments in self-reported psychosocial functioning concerning sexuality, 
healthcare navigation, informational needs, and financial distress, compared to older 
adults matched for sex and cancer type. These differences further illustrate emerging and 
lasting psychological reactions to cancer diagnosis for individuals within this population. 
De and colleagues conducted a systematic review and meta-analysis to quantify 
the presence of mental health disorders among YAs with cancer and identify increased 
risk due to cancer (De et al., 2020). The mental health concerns reported were assessed 
with measures validated against diagnostic criteria, and included anxiety, mood or 
substance use disorders. Four studies met the criteria for participants diagnosed in the YA 
age range. Studies examining mood outcomes reported that 17.8% of YA met clinical 
criteria for a mood disorder and had increased likelihood of depression compared to 
sibling control, and increased likelihood of antidepressant use than population data. 
Similarly, YA testicular cancer survivors had an increased likelihood of substance use 
disorders compared to their matched siblings. Meta-analysis of results across studies 
demonstrated an increased risk of developing anxiety and mood disorders for YAs with 
cancer. This study provides an overview of the limited literature, reflecting increased 
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mental health risks of this population. It suggests that, beyond belonging to an already 
vulnerable demographic, YAs with cancer are an exceedingly at-risk population. 
Individual studies looking at less stringent diagnostic criteria have reinforced 
these findings. Using data from the National Health Interview Surveys in the U.S., Kaul 
et al. compared a sample of YAs diagnosed with cancer in the last five years (n=875) to 
matched peers to evaluate the prevalence rates of distress for these populations (Kaul et 
al., 2017). The prevalence of moderate and severe distress in cancer survivors was 23% 
and 9%, respectively, compared to 17% and 3% in their sex, age, race and ethnicity, and 
geographically matched peers. By controlling for the influence of demographic factors, 
Kaul et al.’s findings further illustrate the additional risk experienced by YAs with 
cancer. Additionally, within this sample, 52.2% of YAs with cancer with severe distress, 
74.7% with moderate, and 94.2% with low distress had not received professional mental 
health help within the last year. While it is difficult to ascertain the direction of this 
relationship, this reflects further severe psychological consequences for YAs with cancer. 
Cancer diagnoses may compound mental health risks for YAs. Nikbakhsh et al. 
used survey data from participants with diverse cancer diagnoses (n=150) to determine 
prevalence rates of anxiety and depression in a sample of patients (Nikbakhsn et al., 
2014). The relationship between cancer type and depression and anxiety was significant, 
with a high prevalence of mental health symptoms reported by participants with stomach 
and breast cancer. Breast cancer is among the most common cancer diagnoses for YAs 
(American Cancer Society, 2020); therefore, diagnosis-specific risk factors for mental 
health have important implications for YAs with cancer.  
Long-Term Mental Health Consequences of Cancer in Young Adults 
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Mental health consequences of cancer are among the long-term implications that 
extend beyond curative treatment. These patterns are demonstrated in a year-long 
longitudinal study conducted by McDonnell and colleagues  that assessed the 
relationships between cancer-related worry and posttraumatic growth in a sample of 153 
YA cancer survivors (McDonnell et al., 2018). Based on qualitative data, researchers 
developed seven questions to assess participants' worry.  Scores of worry remained 
consistent across time, with greatest concerns reported for future health. Participant 
responses further reflect the stable nature of psychological symptoms over time for YAs 
with cancer particularly for worry and preoccupation with future concerns. 
Similarly, a study of child, adolescents and YA cancer survivors with intracranial 
germinoma (n=33, median age =18) collected long-term data regarding neurological 
functioning and quality of life over time (Martens et al., 2014). Outcomes were collected 
through physical examinations, patient interviews, medical chart review, and completion 
of the EORTC QLQ-C30. Participant measures of quality of life were compared to 
normative data for healthy controls, with follow-up ranging widely, with an average of 12 
years. Compared to healthy controls, patient-participants reported significantly worse 
quality of life, with the most considerable social, emotional, and role functioning 
impairments. This study demonstrates that psychosocial consequences and subsequent 
impairments may not resolve over time. 
In addition to poorer quality-of-life, mental health symptoms, including anxiety, 
depression and posttraumatic stress, persist in YAs with cancer years post-diagnosis 
(Ander et al., 2016; Seitz et al., 2010). In a cross-sectional survey, Seitz et al. examined 
current mental health symptoms in a sample of YAs (n=820) diagnosed with cancer at 
 17 
least five years prior and compared them to patient-recruited controls and population data 
(Seitz et al., 2010). Patient-participants who exceeded clinical criteria on measures were 
further assessed via telephone interviews to determine the accurate prevalence of mental 
health disorders in this population. Through interviews, YA male and female cancer 
survivors also reported a significantly higher prevalence of posttraumatic stress (5.7% vs. 
2.1%), depression (14.9% vs. 9.3%), and anxiety disorders (16.5% vs. 11.0%) compared 
to peers. The lasting psychological implications of cancer for YAs is also demonstrated in 
a study conducted by Ander et al. (2016). A diverse sample of patients (n=67) diagnosed 
in adolescence and YAs age 13 to 19  was assessed across eight time-points, beginning 
immediately after diagnosis, throughout their first year, several years following and up to 
10 years post-diagnosis. Symptoms and functioning fluctuated over time with an initial 
reduction in impairments, which rose again by the 10-year assessment point. Mental 
health and vitality declined between assessments at 18-months and 10-years post-
diagnosis and most notably, participants did not experience improvements in overall 
social and emotional functioning and physical health compared to baseline at any point 
during the 10 years after their diagnosis. 
The value of psychosocial care within oncology to improve outcomes and reduce 
healthcare costs underscores the systemic importance of applying this to the YA 
population. Moreover, limited attention and emphasis on YAs in current literature as an 
essential and distinct demographic for exploration emphasizes the immediate need for 
research that addresses the intersection between developmental and mental health 
vulnerabilities for this population. 
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1.5 The Importance of Patient-Oriented Research and Knowledge Translation for 
Young Adults 
It takes 17 years, on average, for academic research to be integrated into clinical 
practice (Morris et al., 2011). Consequently, YAs likely to benefit from existing research 
are not profiting from current findings. Given the developmental and mental health 
vulnerabilities for YAs with cancer, patient engagement, including patient-oriented 
research (POR) and knowledge translation (KT), can help address some of the research 
implementation obstacles. The Canadian Institutes of Health Research have 
conceptualized patient engagement as meaningful and active collaboration across many 
healthcare domains, including governance, priority setting, research, and knowledge 
translation (Canadian Institutes of Health Research, 2019). Specifically, POR represents a 
spectrum of patient engagement throughout the research process; patients taking on 
research roles, providing input regarding priorities and outcomes, to apply this 
information to enhance healthcare. POR principles can be simultaneously applied to 
enhance research quality and access for YAs with cancer. 
The Value of Patient-Oriented Research 
Patient-oriented research has successfully illustrated how patient engagement can 
improve the applicability and appropriateness of research studies (Cashman et al., 2008; 
Chiu et al., 2013; Edwards et al., 2011; Forsythe et al., 2015). Given the developmental 
nuances for YAs, this approach to research could help support autonomy and individual 
identity milestones, particularly for YAs transitioning from pediatric to adult oncology. 
Nationally within Canada, there is conflicting perspective regarding adolescent decision-
making capacity. For YAs who do not meet the age of majority (either 18 or 19, 
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depending on the province), shared decision-making with the family and healthcare 
practitioners is thought to be the best approach (Coughlin, 2018). A systematic review 
(n=21)was undertaken to gauge and identify factors that impact the involvement of 
adolescents and YAs in their healthcare (Pyke-Grimm et al., 2019). Lacking information 
is considered a barrier for decision-making, and YAs demonstrated a preference for clear 
medical information. Conversely, having more experience in coping with illness and 
greater overall maturity were found to contribute an increased engagement in decision-
making. Considering the limited role that younger YAs may play in informing treatment 
decisions, engaging them in research may help share their unique perspective and build 
autonomy in a developmentally and treatment-sensitive way. Additionally, participating 
in research can assist YAs with building the capacity to understand scientific health 
research and support them in addressing their informational needs, improving their 
engagement in treatment decision-making Overall, the involvement of YAs in POR 
creates opportunities for researchers to incorporate the patient experience to enhance the 
applicability and appropriateness of the research conducted and enhance communication 
with YA consumers. 
The Value of Knowledge Translation for Young Adult Research 
POR has illustrated the value of patient engagement in the development and 
facilitation of research studies; however, studies often lack an explanation of patient 
engagement in translating study findings (Forsythe et al., 2015). KT represents a research 
partnership between the target users (i.e. patients, stakeholders) and researchers, using 
their expertise of problems and knowledge gaps, understanding of context, implementing 
findings, and methodological and empirical strategies, respectively (Graham et al., 2006; 
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Kothari et al., 2017). Kazanjian and colleagues used the Knowledge Exchange-Decision 
Making Model to identify barriers impeding the successful implementation of a 
psychosocial program for cancer survivors across Canada (Kazanjian et al., 2012). 
Similarly, Street and colleagues illustrated that education-centred KT strategies like a 
brochure or interactive multimedia program can increase treatment knowledge for 
younger patients by enhancing their ability to engage in meaningful treatment discussions 
with their physicians (Street et al., 1995). Addressing service barriers and increasing 
engagement illustrates how KT's application could address the challenges of effectively 
reaching this population.  
The integration of KT into YA cancer care practices also enhances healthcare 
quality by having YA priorities reflected in treatment outcomes (Zebrack et al., 2007). 
Nielsen et al. created a “shared care program" for newly referred cancer patients, and two 
hundred and forty-eight participants were randomly assigned to the program or care as 
usual (Nielsen et al., 2003). The program included knowledge transfer tools, enhanced 
communication channels, and active patient involvement to share patient healthcare 
responsibility. Communication of pertinent information between patients and healthcare 
practitioners participating in the program contributed to more positive appraisals of care, 
and patients felt their care was more coordinated and had increased contact at follow-up. 
Considering that YAs with cancer engage in less healthcare follow-up (Galan et al., 
2017), POR and KT may address some of the challenges associated with treating this 
population. Integrating YA patients in their care may improve the translation of 
information to patients, and subsequent follow-up and care monitoring. 
An Example in Practice: The YACPRIME Study 
 21 
POR and KT's ability to enhance the quality and applicability of research, increase 
the speed at which results are disseminated and implemented into practice, and support 
the tailoring and efficacy of services for YAs with cancer motivated the undertaking of 
the YACPRIME Study. YAs have been described as the forgotten generation within 
cancer care, with the focus generally on pediatric and adult oncology. Partnership with 
Young Adult Cancer Canada (YACC), a not-for-profit national organization, working to 
"support young adults living with, through, and beyond cancer…[providing connections 
to] peers, [and] bridging …isolation” offered an opportunity to connect with patient 
groups not otherwise captured in the healthcare system (Young Adult Cancer Canada, 
2014). 
The Patient Engagement in Research (PEIR) Framework was created by Hamilton 
and colleagues to provide an empirically structured framework to improve POR 
(Hamilton et al., 2018). Researchers reviewed data collected from patients interviewed 
about their participation in research and analyzed emerging themes related to active 
engagement in research. These themes formed the theoretical framework, which was then 
applied to a review of 18 studies with similar examination patient involvement. Eight key 
principles related to patients' positive engagement in research were identified: 1) having 
procedural requirements that managed the inclusion of patients; 2) ensuring participation 
was convenient for patients; 3) enabling patients to contribute to the scope, direction or 
outcomes meaningfully; 4) team interactions are respectful and convey trust in patient-
partners; 5) having a research environment that is positive and inclusive of patients, 
demonstrating receptivity to patient expertise; 6) patients are offered informational and 
financial support to engage in research actively; 7) patients feel valued by team members, 
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with appropriate recognition of their contributions; and 8) that patient participants see the 
impact of their participation and experience personal benefits from their participation. 
The YACPRIME study offers an excellent example of this framework in practice. 
Within the procedural components requirement of the PEIR framework, the development 
of this study benefited from direct input from the organizational staff at YACC, one of 
whom is a YA cancer survivor. YACC participated actively in each team meeting, 
selected project goals and research questions relevant to the patient population, and acted 
as a liaison to their more extensive YA cancer network. Convenience within the PEIR 
framework refers to patients' ability to dictate their involvement and contributions. The 
researchers defaulted to YACC members to determine their capacity for involvement in 
selecting questions, materials, recruitment, analysis and dissemination of the study. 
Quality team interactions require respectful rapport and effective communication style, 
and for effective implementation of the PEIR framework, patients also need to feel valued 
as contributors. In the YACPRIME Study, the success of the team interactions was 
reflected by the amount of input patient partners provided, illustrating their comfort with 
the team dynamics. Further, as an illustration of how YACCs expertise was valued, they 
were always consulted prior to presenting research findings to ensure the tone reflected 
the organizational goals. Another theme of the PEIR framework is providing information 
and financial support to the partners. Grant funding was secured to support patient 
partners in attending and presenting at national and international conferences, and 
emphasis was placed on navigating the research process and training patients on how to 
interpret findings. The final component for the PEIR Framework was to ensure benefits 
for patient partners, specifically the ability to see the impact of their participation on 
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others, organizations, and resources and gain skills and enhance their knowledge. Within 
the YACPRIME study, patient and organizational partners were able to generate 
knowledge that changed how YACC offered programs to meet YAs support and 
informational needs. Additionally, members of YACC gained insight into the research 
process, including how to interpret research findings, present study findings at research 
conferences and contribute to academic articles, which in turn contributed to greater 
advocacy. 
1.6 Summary and Objectives 
YAs with cancer face significant developmental challenges resulting from cancer 
diagnosis during this stage of life. To adequately address the different needs of YAs, POR 
that characterizes population-specific risk factors and illustrates the lasting psychological 
consequences of cancer is needed. Based on patient collaboration with YACC, the 
following research objectives were chosen to better understand the psychological 
challenges experienced by YAs and identify increasingly vulnerable YAs within this 
community.  
The primary research objectives of this thesis are as follows:  
1. Compare levels of distress in YAs with cancer to non-cancer peers matched on 
age, sex, and education and examine which factors are related to an increased 
likelihood of experiencing high levels of distress in YAs with cancer. 
2. Document the prevalence and examine factors associated with a specific type of 
distress, fear of cancer recurrence, in YAs with cancer.  
The two studies included in this investigation which reflect these objectives have 
been published and their respective references are included at the outset of each chapter. 
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2.1 Abstract 
OBJECTIVE: Young adulthood can be a difficult period of development and disruption 
of age-related milestones can impact psychological well-being. This study examined 
whether psychological distress differs in young adult (YA) cancer survivors compared to 
their non-cancer peers, and identified factors related to high distress in YA cancer 
survivors.  
METHODS: Canadian YAs (n=448) who completed the YACPRIME Study, diagnosed 
with cancer between the ages of 15-39, were compared to age, sex, and education-
matched controls (n=448) randomly sampled from the 2012 Canadian Community Health 
Survey – Mental Health. The primary measure was the Kessler Psychological Distress 
Scale (K10). Groups were compared using independent samples t-tests and chi-square 
tests of independence. Logistic regression was used to examine the factors associated 
with high (moderate/severe) distress for YA cancer survivors.  
RESULTS: YA cancer survivors reported significantly higher distress than their matched 
peers (24.89 vs. 15.75; p <.0005). In the multivariate model, greater years of education 
was associated with decreased likelihood of high distress [Adjusted Odds Ratio 
(AOR)=0.84, p=.001]. Compared to those working, being in school (AOR=6.81, p=.003) 
or not in school/working (AOR=4.13, p<.0005) were associated with higher distress. 
Psychological factors associated with high distress in YA cancer survivors included body 
image dissatisfaction (AOR=1.09, p<.0005), poor social support (AOR=5.19, p=.011), 
and elevated fears of cancer recurrence (maladaptive: AOR=6.39, p=.001; clinical: 
AOR=12.31, p<.0005).  
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CONCLUSIONS: YA cancer survivors experience significantly greater distress than 
their non-cancer peers. This distress is associated with modifiable factors such as body 
image dissatisfaction, social support, and fear of cancer recurrence, illustrating key areas 




Psychological distress describes the collective unpleasant or painful psychosocial 
responses that impair effective coping with cancer. Psychological distress can present as  
depression, anxiety, somatic symptoms, impaired relationships, and existential concerns 
(Howell & Olsen, 2011). The pervasiveness of distress in cancer, coupled with under-
reporting due to inaccurate assessment, motivated the adoption of distress as the sixth 
vital sign of patients’ health and well-being (Bultz & Carlson, 2005). Initial studies 
suggest that young adults (YAs) experience more prevalent and severe levels of distress 
(Lang et al., 2015; Wang et al., 2014), compared to other aged patients and their non 
cancer peers, indicating that cancer in young adulthood may come with additional 
psychosocial burden (Kaul et al., 2017). Generally, young adulthood is a complex 
developmental stage, with an emphasis on transition, autonomy, and individual identity 
(Zirkel & Cantor, 1990), and is also the age of onset for many mood and anxiety disorders 
(Kessler et al., 2007). Compared to peers, YA cancer survivors are more likely to report 
poor perceived health, and anxiety (15.1% vs. 5.4%) and mood disorder diagnoses 
(14.8% vs. 5.7%), a difference not observed among the older adults (Lang et al., 2018). 
Unfortunately, this study was limited by estimating the prevalence of mental health 
concerns using previous mental health diagnoses and perceived mental health with a 
single item. Further, patients with metastatic cancer were excluded from this study, while 
childhood cancer survivors who were currently within the YA range were included. As 
such, more research is needed to draw more definitive conclusions about the 
psychological consequences of being diagnosed with cancer in young adulthood.  
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There is evidence that other demographic, disease, and physical and psychological 
characteristics are related to higher levels of distress. Sex may partially account for 
differences, as females are more likely to report psychosocial concerns as a result of a 
cancer diagnosis and experience a higher prevalence of severe distress (Koyama et al., 
2016; Wang et al., 2014). YAs also often face significant financial stress as a result of 
cancer and report more considerable financial difficulties than older adults (Hall et al., 
2012). Disease severity and somatic symptoms (Koyama et al., 2016), uncertainty 
regarding treatment (Neville, 1998), and fears of recurrence (Lebel, Beattie, et al., 2013) 
have also been associated with higher levels of distress. Further, evidence also suggests 
poorer physical health, sleep disturbances (Daniel et al., 2016; Mehnert et al., 2018), body 
image concerns (Koyama et al., 2016), and social isolation (Brett et al., 2014), may 
contribute to the increased prevalence of distress in YAs. Studying the impact of age in 
connection with other demographic, clinical cancer, and psychosocial variables will 
provide essential insights into how to address distress for YA cancer survivors.  
To determine the psychosocial burden of cancer in YAs, the primary aim of the 
current study was to compare YA cancer survivors and non-cancer peers matched on age, 
sex, and education using a global measure of distress. The secondary aim of this study 
was to examine which demographic, cancer, and psychosocial factors are related to an 







This study utilized data from the Young Adults with Cancer in their Prime 
(YACPRIME) study. Participants had to have been diagnosed with cancer between the 
ages of 15 and 39 (Adolescent and Young Adult Oncology Progress Review Group, 
2006), reside in Canada, and currently be 19 years or older, in accordance with policy and 
ethics approval from Memorial University’s Interdisciplinary Committee on Ethics in 
Human Research (ICEHR). Participants were recruited through direct emails, media 
promotion, online advertisements, social media posts, and referrals from healthcare 
professionals. Data from this survey were collected between June 2017 and March 2018 
using the platform Survey Monkey (https://www.surveymonkey.com/). Participants 
completed a digital consent form prior to accessing the survey. Individuals could provide 
contact information separately to be entered to win an online gift card valued at $25. 
This project was created in collaboration with Young Adult Cancer Canada 
(YACC), a national network dedicated to providing support and advocacy for YA cancer 
survivors. Discussions with members of YACC were held to derive patient objectives and 
concerns for investigation in the present study. YAs reported often feeling different and 
isolated from their peer as a result of cancer and treatment (D'Agostino & Edelstein, 
2013). Therefore, the focus of this study was to address YAs questions by helping to 
understand how their psychosocial needs compare to their peers and to ultimately reduce 
self-stigma associated with their different experiences of distress.  
Six hundred and twenty-two individuals completed the YACPRIME study; 
however, for the present study, we restricted the sample to those currently 39 years or 
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younger (n = 508). An additional 51 participants were excluded that did not respond to all 
10-items that comprised the dependent variable. We were not able to identify an 
appropriate non-cancer peer match for nine additional participants. The remaining sample 
was comprised of 448 YA cancer survivors and 448 non-cancer peers. Participants in the 
YACPRIME survey were asked to report both their sex and gender. Of the 448 
participants, only six endorsed “Other”; three participants identified as gender fluid or 
queer, one identified as femme, and two participants did not indicate their gender. 
Further, in the Canadian Community Health Survey (CCHS) dataset there was no variable 
for gender, which would have prevented us from being able to identify a population 
match. Seeing that we did not want to exclude participants from the analysis on the basis 
of belonging to a gender minority group, sex was used as the variable for the analysis and 
here forth reference to female refers to sex.  
Case Matching  
Case matching was used to create a comparison sample with data obtained from 
the 2012 CCHS - Mental Health (CCHS-MH) (Canadian Community Health Survey - 
Mental Health (CCHS), 2013). The data from the 2012 survey were used as this was the 
last time the Kessler Psychological Distress Scale (K10) was administered nationally by 
Statistics Canada. CCHS-MH participants were 15 years of age or older, living in any 
province, and excluded individuals living on reserves, members of the armed forces, or in 
institutionalized settings. The CCHS-MH was cross-sectional and sampled respondents 
based on sex, age, and location, via computer-assisted interviewing. For the current study, 
additional participants were excluded if they responded affirmatively to having cancer, or 
having received a previous cancer diagnosis.  
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To match participants, frequencies of age, sex, and educational attainment were 
calculated for the YACPRIME participants. Controlling for these characteristics, all 
possible CCHS participants who met the demographic criteria were isolated and then 
randomly sampled to reflect the same frequencies as the YACPRIME participants. The 
CCHS non-cancer peers were merged with the YACPRIME dataset to compare responses 
between groups.  
Dependent Variable 
The K10 was used to measure participants’ distress, symptoms of anxiety, and 
depression, within the last month (Andrews & Slade, 2001). The K10 consists of 10 items 
rated on a 5-point Likert scale, which for this administration, ranged from 1 to 5 (“None 
of the time” to “All of the time”) for each item and provided an overall measure of 
distress between 10 to 50. Total scores < 20 do not indicate distress, scores ranging from 
20-24 are suggestive of mild distress, scores from 25-29 are indicative of moderate 
distress, and scores greater than or equal to 30 suggest severe distress (Andrews & Slade, 
2001). The K10 has demonstrated adequate sensitivity and specificity in identifying 
individuals who meet the criteria for anxiety and affective disorders, as well as the ability 
to discriminate between individuals without disorders (Andrews & Slade, 2001). The K10 
has been utilized with an Australian adolescent and YA population (n=196) to measure 
symptoms of anxiety and depression (McCarthy et al., 2016). The K10 was utilized across 
the YA cancer survivor and matched peer samples. 
Given the study's objectives, participants with none or mild distress scores were 
classified as low distress, and participants with moderate and severe distress scores were 
classified as high distress. Cronbach’s alpha was 0.90 within the sample. 
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Independent Variables  
Relevant sociodemographic variables (age, sex, education, income, relationship 
status, living arrangement, parental status, race/ethnicity) for both samples and factors 
related to participants’ cancer diagnosis and treatment were collected through self-report 
and chosen based on theoretical support and patient and stakeholder collaborator input 
(Kazak et al., 2010).  
We used a single item from the Short-Form Health Survey 12 (SF-12) as an 
estimate of perceived health quality for both samples. On this item, a score of 1 refers to 
"excellent" health and a score of 5 reflects "bad” health (Ware et al., 1996).  
Self-reported sleep quality within the last month was evaluated using the 
Pittsburgh Sleep Quality Index (PSQI). The PSQI includes 19 items, and the total score 
ranges from 0-21 with higher scores indicating worse sleep quality, using a total cutoff 
score of > 5 to indicate impaired sleep quality (Buysse, 1989). This measure has sufficient 
construct validity and internal consistency in the assessment of sleep quality in 
individuals with cancer and has been used in an adolescent and YA population (Daniel et 
al., 2016). Cronbach’s alpha was 0.82 within the sample.  
Participants' body image dissatisfaction as a result of cancer was evaluated using 
the Body Image Scale (BIS), which has 10 items rated within the past week reflecting 
affective, behavioral, and cognitive domains (Falk Dahl et al., 2010). Acceptable 
measures of internal consistency, reliability, and clinical validity have been demonstrated 
for this measure (Melissant et al., 2018). Cronbach’s alpha was 0.92 within the sample.  
Perceived social support was measured using the Medical Outcome Study Social 
Support Survey (MOS-SSS) (Sherbourne & Stewart, 1991). The MOS-SSS is a 19-item 
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scale, and scaled scores range from 0-100, with higher scores indicating better social 
support (Sherbourne & Stewart, 1991). The mean total of perceived social support in a 
chronic illness population and standard deviation reported in the validation of the measure 
was used to categorize responses (M = 70.1, SD = 24.2) as poor (≤ 45.9), average (46.0-
94.2) and high perceived social support (≥94.3) (Sherbourne & Stewart, 1991). The 
MOS-SSS has adequate reliability, and has been validated in cancer and chronic illness 
populations (Sherbourne & Stewart, 1991). Cronbach’s alpha was 0.95 within the sample.  
Participants' fears of cancer recurrence were measured using the nine-item Fear of 
Cancer Recurrence Inventory-Short Form (FCRI-SF) (Simard & Savard, 2015). Scores on 
the FCRI-SF can be used to measure the severity of FCR; scores of < 16 are suggestive of 
minimal levels of FCR, scores of 16-21 are suggestive of maladaptive levels of FCR, and 
scores of ≥22 indicate clinically significant levels of FCR. These cutoff scores have 
demonstrated high sensitivity and adequate specificity (Fardell et al., 2018; Simard & 
Savard, 2015). Cronbach’s alpha was 0.85 within the sample. 
Statistical Analysis 
Descriptive statistics were used to characterize the sample’s demographic and 
clinical characteristics. An independent samples t-test was used to examine differences in 
distress between YA cancer survivors and the matched-sample. Examination of the data 
for the non-cancer YAs revealed that K10 scores were positively skewed 1.90 (standard 
error = 0.12) with a positive kurtosis of 4.90 (standard error = 0.23). There was also a 
slight positive skew for the YA cancer survivors (0.39, standard error = 0.12) but kurtosis 
was normal (-0.28, standard error = 0.23). Given the large, equal sample size for cancer 
and non-cancer conditions, and the desire to obtain a diverse population, the robustness of 
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the test will account for these violations (Laerd Statistics, 2015). Participants were also 
compared on demographic variables consistently measured across groups, to further 
illustrate population differences and similarities. 
 Binomial logistic regression was used to examine factors related to increased 
likelihood of experiencing high levels of distress in the YA cancer survivor group. 
Variables with established clinical cutoffs were used categorically to help inform clinical 
decision making and ease interpretation and communication of results to patient partners 
and stakeholders. Univariate binomial logistic regressions were used to identify 
independent variables associated with high distress (scores of ≥25 on the K10 (Andrews 
& Slade, 2001)). Covariates with p values <.10 were then simultaneously entered into a 
multiple binomial logistic regression model (Bursac et al., 2008). Linearity of the 
continuous variables with respect to the dependent variable were assessed via the Box-
Tidwell procedure (Box & Tidwell, 1962). A Bonferroni correction was applied using all 
21 terms in the model resulting in statistical significance being accepted when p < .00238. 
All continuous independent variables were found to be linearly related to the dependent 
variable. Variables in the multivariable model were assessed for multicollinearity using 
linear regression (Hair et al., 2006). All variables had a variance inflation factor <2, 
demonstrating no violations of multicollinearity. In examining casewise diagnostics for 
outliners, five cases had standardized residual scores that exceeded two standard 
deviations and were removed from the model. Analyses were conducted using SPSS 
Version 27. All tests were two-sided, with p < 0.05 indicating statistical significance for 




Participants with cancer had a mean age of 32.22 years (SD = 4.72).  The majority 
of participants were Caucasian (88.2%), female (86.8%), in committed relationships 
(67.0%), and graduated from post-secondary school (68.8%).  
The most commonly reported cancer diagnoses/categories included blood cancers 
(27.9%), breast cancer (24.8%), and female genitourinary cancers (11.1%). Participants 
reported an average time since diagnosis of 3.78 years (SD = 3.83) and the most common 
cancer stages were II (29.0%) and III (23.2%). Table 1 and Table 2 provide further 
descriptive characteristics of the YA cancer sample.   
Matched Sample Comparison 
 Matching participants produced equivalent groups with no significant differences 
in age, sex, and education. Independent samples t-tests were used to compare differences 
in distress and perceived health quality for YAs with and without cancer. Distress was 
significantly higher for YA cancer survivors (M = 24.89, SD = 7.76) than YAs without 
cancer (M = 15.75, SD = 5.77), t (825.862) = 19.995, p <.0005, Cohen’s d = 1.336. 
Similarly, perceived health quality was worse for YA cancer survivors (M = 3.04, SD = 
0.96) than YAs without cancer (M = 2.17, SD = 0.93), t (837) = 13.341, p <.0005, 
Cohen’s d = 0.925.  
Chi-square tests of independence were conducted to determine whether there was 
an association between participant group (YA cancer survivors vs. matched peers) and 
marital status, living arrangement, and personal income, respectively. There was a 
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statistically significant association between marital status and cancer diagnosis, χ2(2) = 
17.294, p < .0005 (Table 1). Although the association was small (Cramer's V = .139) 
(Cohen, 1988 ), YA cancer survivors were more likely to be in a committed relationship 
(Odds ratio [OR] = 1.632) and matched peers were more likely to be divorced or 
separated (OR = 2.531). The association between living arrangement and cancer 
diagnosis was also statistically significant, χ2(6) = 160.228, p < .0005. YA cancer 
survivors were 8.6 times more likely to be unattached and living with others (OR = 8.611) 
and 1.8 times more likely to be living with parent(s) and sibling(s) (OR = 1.838) than 
matched peers, and the association was moderately strong (Cramer's V = .424) (Cohen, 
1988 ).  In contrast, matched peers were 3.4 times more likely to report living with a 
partner (OR = 3.355) and 3.5 times more likely identify as a single parent (OR =3.553), 
than YA cancer survivors. There was a statistically significant association between 
personal income and cancer diagnosis, χ2(2) = 141.388, p < .0005, with YA cancer 
survivors being more likely to report an annual personal income of < $20,000 (OR = 
7.500) and between $20,000-$40,000 (OR = 1.987) than matched peers, with a 
moderately strong association (Cramer's V = .404) (Cohen, 1988 ). While YAs without 
cancer were 5.5 times more likely to have an income of $40,000 annually than YA cancer 
survivors (OR = 5.474).  
Table 1. Demographic information and comparison of matched sample. 
Variable YACPRIME (cancer) 
CCHS 
(no cancer)   
Test statistic Effect Size Comparison 
Effect 
Size 
Age   χ
2(3) = 0.000 
p =1.000   
20-24 33 (7.4%) 33 (7.4%)    
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25-29 83 (18.5%) 83 (18.5%)    
30-34  170 (37.9%) 170 (37.9%)    
35-39  162 (36.2%) 162 (36.2%)    
Sex      
Male 59 (13.2%) 59 (13.2%) χ
2(1) = 0.000 
p =1.000   
Female 389 (86.8%) 389 (86.8%)    
Education   χ
2(3) = 0.000 
p =1.000   
< Secondary school 11 (2.5%) 11 (2.5%)    
Secondary school graduate 9 (2.0%) 9 (2.0%)    
Some post-secondary 120 (26.8%) 120 (26.8%)    
Post-secondary graduate 308 (68.8%) 308 (68.8%)    
Marital Status   χ
2(2) = 17.294, 
p < .0005   
In a committed relationship 297 (67.0%)  248 (55.5%)  YAC:CCHS 1.632* 
Divorced or separated 17 (3.8%) 41 (9.2%)  CCHS:YAC 2.531** 
Single 129 (29.1%) 158 (35.3%)  CCHS:YAC 1.331 
Living Arrangement   3   
Unattached, living alone 72 (16.1%) 92 (21.7 %)  CCHS:YAC 1.451 
Unattached, living with 
others 139 (31.0%)  21 (5.0%)  YAC:CCHS 8.611*** 
Living w/ spouse/partner 25 (5.6%) 70 (16.5%)  CCHS:YAC 3.355** 
Parent w/ spouse/partner, 
children 133 (29.7%)  
154 
(36.4%)  CCHS:YAC 1.356 
Single parent w/ children 17 (3.8%) 52 (12.3%)  CCHS:YAC 3.553** 
Living with parent, 
with/without siblings 62 (13.8%) 34 (8.0%)  YAC:CCHS 1.838* 





141.388, p < 
.0005 
  
< $20,000.00 152 (34%) 27 (6.4%)  YAC:CCHS 7.500*** 
$20,000.00 to less than 
$40,000.00 103 (23.0%) 55 (13.1%)  YAC:CCHS 1.987* 
$40,000.00 or greater 192 (43.0%) 338 (80.5%)  CCHS:YAC 5.474*** 
Perceived Health Quality 
(higher scores refer to 
worse health) 
3.04  
(SD = 0.96) 
2.17  
(SD = 0.93) 







(SD = 7.77) 
15.75 
(SD = 5.78) 




* Small effect size, ** Medium effect size, *** Large effect size 
 
Table 2. Additional sociodemographic variables for young adults with cancer sample.  
 Frequency (%) 
n = 448 
Race/Ethnicity  
 Caucasian  395 (88.2%) 
 Asian  15 (3.3%) 
 Multi-racial/Ethnic Identity 16 (3.6%) 
 Aboriginal/First Nations 11 (2.5%) 
 Other 11 (2.5%) 
Children  
 No children 296 (66.1%) 
 1+ children 152 (33.9%) 
Years of Education (Mean, SD) 17.13 (3.08) 
Cancer Diagnosis  
 Breast 111 (24.8%) 
 Female Genitourinary  48 (10.7%) 
 Male Genitourinary 6 (1.3%) 
 Thyroid 37 (8.3%) 
 Blood Cancers 125 (27.9%) 
 Head & Neck 41 (9.2%) 
 Gastrointestinal 39 (8.7%) 
 Skin 114 (3.1%) 
 Multiple Types 5 (1.1%) 
 Other 22 (4.9%) 
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Cancer Stage  
 Stage 1 59 (13.2%) 
 Stage 2 130 (29.0%) 
 Stage 3 104 (23.2%) 
 Stage 4 62 (13.8%) 
 Don’t Know 60 (13.2%) 
 Not Applicable 34 (7.6%) 
Treatment Status  
 Not on treatment 298 (66.5%) 
 Currently on treatment 150 (33.5%) 
Metastatic Cancer Status  
 No 349 (77.9%) 
 Don’t Know 38 (8.5%) 
 Yes 61 (13.6%) 
Time Since Diagnosis, Mean Years (SD) 3.78 (3.83) 
 < 2 years  149 (32.6%) 
 2 – 4 years 167 (37.2%) 
  5+ years 130 (29.8%) 
 Missing 2 (0.4%) 
Psychological Distress  
 No clinical distress 27.2% 
 Mild clinical distress 24.3% 
 Moderate clinical distress 20.5% 
 Severe clinical distress 27.9% 
 
Factors Associated with High Levels of Psychological Distress 
Collectively, 72.8% of YA cancer survivors exceeded the clinical cutoff of 20 for 
mild distress on the K10 (Table 2). Specifically, 24.3% reported mild distress (20-24), 
20.5% of participants reported moderate distress (25-29), and 27.9% reported severe 
distress.  Separate univariate binomial logistic regression models were used to identify 
significant independent factors associated with high distress. For complete univariate 
analysis see Table 3. All significant independent variables were entered into a 
multivariate binomial logistic regression. The logistic regression model was statistically 
significant, χ2(18) = 164.072, p < .0005, and these predictors explained 51.6% of the 
variance (Nagelkerke R2) in high distress. The multivariate model correctly classified 
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78.2% of cases; sensitivity was 77.7%, and specificity was 78.7%, while the positive 
predictive and negative predictive values were 78.2% and 78.2%, respectively.  
In the multivariate model, participants who reported were not currently working or 
enrolled in school (Adjusted Odds Ratio [AOR] = 4.134 [2.060, 8.296], p < .0005), or 
identified as students (AOR = 6.813 [1.942, 23.906], p =.003), were more likely to 
experience high distress than individuals who reported being employed. Similarly, 
participants with greater body image dissatisfaction as a result of cancer were more likely 
to experience high distress (AOR = 1.088 [1.047, 1.130, p =.0005) than those with less 
dissatisfaction. Compared to individuals with high-perceived social support, only those 
individuals with poor perceived social support (AOR = 5.191 [1.468, 18.350], p=.011) 
were more likely to experience high distress. Fear of cancer recurrence of any severity 
remained significantly related to high distress. Individuals who reported maladaptive 
levels and clinical levels of fear of cancer recurrence were six times (AOR = 6.386 
[2.071, 19.696], p = .001) and almost 12 times more likely to experience high distress 
(AOR = 12.311 [4.226, 35.863], p <.0005), than individuals with minimal levels. At the 
multivariate level, living arrangement, income, metastatic cancer status, treatment status, 







Table 3. Factors associated high levels of psychological distress (K10 scores of ≥ 24) in young 
adults with cancer. 
 Univariate Logistic Regression Analysis 
 
Multivariate Logistic Regression 
Analysis 
 
Odds Ratio [95%CI] p 
Adjusted Odds Ratio 
[95%CI] p 
    <.0005* 
Age 0.980 [0.942, 1.020] .321   
Sex     
Male (Ref) 1    
Female 1.224 [0.706, 2.124] .472   
Relationship Status     
Single (Ref) 1    
In a relationship 0.743 [0.500, 1.105] .142   
Children     
No children (Ref) 1    
1+ children 1.191 [0.805, 1.761] .383   
Years of Education 0.868 [0.813, 0.927] <.0005 0.837 [0.757, 0.927] .001 
Living Arrangement     
Alone (ref) 1  1  
With others 0.571 [0.357, 0.915] .020 0.527 [0.235, 1.182] .120 
Current Employment 
Status  <.0005†   
Working part/full time 
(Ref) 1  1  
In school part/full time 2.341 [1.128, 4.859] .022 6.813 [1.942, 23.906] .003 
Not working or in school 4.512 [2.781, 7.320] <.0005 4.134 [2.060, 8.296] <.0005 
Income  .002†   
< $20,000 (Ref) 1  1  
$20,000 to < $40,000 0.742 [0.448, 1.226] .244 0.726 [0.322, 1.640] .442 
$40,000 to < $60,000 0.632 [0.371, 1.077] .091 2.249 [0.908, 5.572]  .080 
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$60,000 or more 0.374 [0.223, 0.626] <.0005 1.218 [0.532, 2.791] .641 
Cancer Stage at 
Diagnosis  .260†   
Stage 1 (Ref) 1    
Stage 2 0.519 [0.278, 0.969] .040   
Stage 3 0.660 [0.346, 1.259] .207   
Stage 4 0.529 [0.257, 1.089] .084   
Don’t Know 0.870 [0.419, 1.807] .710   
Not Applicable 0.541 [0.231, 1.271] .159   
Current Metastatic 
Cancer Status  .025†   
No (Ref) 1  1  
Don’t Know 2.325 [1.151, 4.693] .019 2.148 [0.660, 6.991] .204 
Yes 1.522 [0.881, 2.632] .132 0.853 [0.321, 2.271] .751 
Treatment Status     
Not currently on treatment 
(Ref) 1  1  
On treatment 1.579 [1.064, 2.344] .023 1.236 [0.611, 2.501] .556 
Time Since Diagnosis  .003†   
< 2 years (Ref) 1  1  
2 – 4 years  0.768 [0.492, 1.200] .247 0.786 [0.377, 1.639] .521 
 5+ years 0.443 [0.274, 0.716]  .001 0.673 [0.297, 1.526] .343 
Pittsburgh Sleep Quality Index (PSQI)    
Good Sleep (≤ 5) (Ref) 1  1  




1.147] <.0005 1.088 [1.047, 1.130] <.0005 
Social Support (MOS-SSS) <.0005†   
High (94.3+) (Ref) 1  1  
Average (45.9-<94.3) 2.611 [1.268, 5.374] .009 1.354 [0.498, 3.680] .552 
Poor (<45.9) 7.342 [3.134, 17.200] < .0005 5.191 [1.468, 18.350] .011 
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Fear of Cancer Recurrence – Short Form 
(FCRI-SF) <.0005†   
Adaptive FCR (<16) (Ref) 1  1  
Maladaptive FCR (16-21) 2.971 [1.400, 6.302] .005 6.386 [2.071, 19.696] .001 
Clinical FCR (22+) 8.953 [4.481, 17.887] <.0005 12.311 [4.226, 35.863] <.0005 
Continuous variables were categorized based on available data, or population distribution 
within the sample. 
† Overall significance for variables with more than two categories at the univariate level. 
* Significance for the overall multivariate model. 
2.5 Discussion 
Distress Differences between YA Cancer Survivors and Matched Peers 
YA cancer survivors experience significantly greater levels of distress and report 
poorer perceived health quality than their age, sex, and education matched peers. YA 
cancer survivors had moderate distress on average while their matched peers reported 
subclinical levels. Moderate scores of the K10 are associated with an approximately 30% 
probability of meeting DSM-IV criteria for an anxiety and/or mood disorder (Andrews & 
Slade, 2001). In comparison, subclinical scores reported by matched peers were 
associated with 3.8% prevalence for anxiety disorders and 3.0% for mood disorders. 
Significant differences were also noted in income and living arrangement between YA 
cancer survivors and their matched peers, suggesting that a diagnosis of cancer in young 
adulthood compromises the ability to keep pace with peers (Parsons et al., 2012; Rabin, 
2019).  
Factors Associated with Psychological Distress in YA Cancer Survivors 
The severity of distress was largely independent of demographic and cancer 
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variables. The only demographic variables that remained significantly associated with 
distress after accounting for other factors were employment status and years of education. 
In contrast, body image dissatisfaction, fear of cancer recurrence, and poor social support 
were all associated with high levels of distress. Body image dissatisfaction and changes in 
appearance as a result of cancer can increase distress by acting as reminders of illness, 
which can contribute to social isolation and feelings of being different from peers 
(D'Agostino & Edelstein, 2013). Symptoms of depression have been associated with 
feeling unattractive as a result of treatment-related scars in YAs with cancer (Olsson et 
al., 2018). While this relationship may be bidirectional, qualitative report by YAs 
suggests that significant observable changes may initiate distress, which perpetuates body 
image concerns (Brierley et al., 2019). Further, fear of cancer recurrence can contribute to 
behavioural changes, including avoidance (Simard et al., 2010) of emotionally evocative 
stimuli (Simard et al., 2010), which can perpetuate distress in the long term. Lastly, YAs 
who report poorer perceived social support are more vulnerable to higher levels of 
distress. Social support through online communities or community resources may help to 
reduce isolation (Coyne et al., 2016) and psychological adjustment to cancer (Haluska et 
al., 2002). Additional research is needed to clarify the direction of these relationships. 
Limitations  
Despite having a large, geographically diverse sample of YA cancer survivors, a 
number of limitations should be acknowledged. First, data from the YACPRIME study 
was collected five years after that of the matched non-cancer peers. Thus, variation in 
scores may reflect population differences in mental health; however, a Canadian 
population-based study demonstrated consistency in prevalence of mental health concerns 
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over time (Chiu et al., 2020). Further, similar population discrepancies have been reported 
in other studies, with more mental health concerns reported by YA cancer survivors 
(Lang et al., 2018), and higher prevalence rates for moderate and severe distress within 
this population (Kaul et al., 2017). While it is possible that sociocultural factors may 
contribute to the population differences, they do not sufficiently explain the variance in 
these scores. Second, the YACPRIME and CCHS surveys used different enrolment 
strategies. Participants in the CCHS were systematically sampled whereas participants in 
the YACPRIME study were recruited. Consequently, participants within each sample 
may have different motivations for completing the survey; YA cancer survivors could 
have a stronger desire to convey difficulties leading to elevated scores. However, our 
findings are consistent with other comparative studies, which supports the presence of 
actual differences. Lastly, the sample in this study represents an older YA group which 
may limit the ability to compare these results to other studies with representation from 
those currently between 15-20. Individuals belonging to racial, ethnic, and gender 
minorities were also under-represented in our data, despite efforts to recruit diverse 
populations. This pattern continues to miss the detection of health outcome nuances 
specific to these demographic populations within oncology. Additionally, substantial 
discrepancies between male and female participants may also impact the generalizability 
of study findings. Research examining emotion expression proports that women tend to 
use more expressive language to describe their emotional responses (Goldshmidt & 
Weller, 2000), and demonstrate greater emotional expression (Chaplin, 2015). 
Alternatively, men are more likely than women to exhibit higher levels of alexithymia, 
the inability to identify or describe emotions (Levant et al., 2009), but demonstrate equal 
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levels of physiological arousal to emotions (Chaplin, 2015), suggesting it is possible that 
the responses may not reflect the psychological or emotional experiences experienced by 
men and external validity of the presenting findings. Future research must listen to and 
prioritize research objectives reported by these particular patient groups to decrease 
barriers to participation in research and illuminate population specific needs to improve 
healthcare outcomes.  
Clinical Implications 
Being unemployed increases the risk of experiencing high distress for YA cancer 
survivors, and coupled with significant income discrepancies with matched peers, 
emphasizes the need for economic intervention. The development of formal screening 
measures and clinician-initiated conversations regarding patient financial concerns offer 
an opportunity for intervention regarding well-being for YA cancer survivors (Carrera et 
al., 2018). Additionally, support in engaging in part-time work or school may also assist 
individuals in making the transition to employment or education post-treatment (Gupta et 
al., 2016). Empirically supported treatments for body image dissatisfaction (Mehnert et 
al., 2011), and fear of cancer recurrence (van de Wal et al., 2018) have demonstrated the 
ability to reduce overall distress. Additionally, the importance of social support for YAs 
with cancer suggests effective interventions for this population should emphasize and 
foster connection between YAs with cancer (Richter et al., 2015). Addressing geographic, 
logistical, and institutional barriers to accessing these interventions is the necessary next 





 YA cancer survivors experience higher levels of distress compared to their peers, 
reflecting the disruptive developmental impact of a cancer diagnosis during young 
adulthood. Individuals belonging to this population who have less education, are not 
employed, are dissatisfied with their body image as a result of cancer, have poor social 
support, and report high levels of fear of cancer recurrence are increasingly vulnerable. 
These identified risk factors are modifiable and signify priority areas for additional 













Chapter 3: Prevalence and Factors Associated with Fear of Recurrence in a Mixed 














2 Chapter Reference for Publication: 
Lane, B. E., Garland, S. N., Chalifour, K., Eaton, G., Lebel, S., Galica, J., Maheu, C., Simard, S. (2019).  
Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with  
cancer. J Cancer Surviv, 13(6), 842-851. doi:10.1007/s11764-019-00802-9 
 50 
3.1 Abstract 
PURPOSE: This study examined the prevalence of and factors associated with fear of 
cancer recurrence (FCR) in young adults (YAs).  
METHODS: YAs diagnosed with cancer between the ages of 15-39 in Canada (n=461), 
who were currently 19 years or older, completed the Young Adults with Cancer in their 
Prime (YACPRIME) Study. The Fear of Cancer Recurrence Inventory Short Form 
(FCRI-SF) was the primary outcome. Scores ≥ 16 on the FCRI-SF indicate problematic 
levels and scores ≥ 22 represent clinically significant FCR. Covariates included 
demographic, clinical cancer variables, and co-morbid symptom measures. Univariate and 
multivariate logistic regression analyses were performed to identify variables associated 
with FCR.  
RESULTS: Participants were predominantly female (88%) with a mean age of 32 years 
(SD=4.7). Problematic levels of FCR were present in 84% of YAs, and 59% met or 
exceeded the cutoff for clinically significant FCR. In the multivariate model, time since 
diagnosis of 5+ years was associated with a reduced likelihood of clinical FCR (Adjusted 
Odds Ratio [AOR]=0.354; p=.004), while having a previous recurrence was related to 
increased likelihood (AOR=3.468, p=.001). Other factors associated with clinical FCR in 
YAs with cancer were psychological distress (Mild: AOR=2.947, p=.003; Moderate: 
AOR=5.632, p<.0005; Severe: AOR=8.877, p<.0005), and cancer-related body image 
dissatisfaction (AOR=2.311, p=.004).  
CONCLUSIONS: FCR is a pervasive problem for YAs diagnosed with cancer, with 
previous recurrence and psychological difficulties as factors associated with higher 
degree of fear.  
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IMPLICATIONS: Psychosocial interventions for YAs targeting depression and anxiety 
should also prioritize the treatment of FCR.  
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3.2 Introduction 
Young adults (YAs) with cancer will spend the majority of their lives coping with 
cancer beyond the physical treatment of disease (Keegan et al., 2016). As per the National 
Cancer Institute (Adolescent and Young Adult Oncology Progress Review Group, 2006; 
Aubin et al., 2011), YAs encompass those aged 15 through 39 at diagnosis. YA cancer 
survivors experience impaired physical, emotional, cognitive, functional, and social 
quality of life up to 10 years post-diagnosis (Martens et al., 2014). There is often an 
expectation that life should return to ‘normal’ after treatment (Fitch et al., 2018), and 
patients are frequently unprepared for the long-term effects of cancer. Fear of cancer 
recurrence (FCR), defined as “fear, worry, or concern relating to the possibility that 
cancer will come back or progress” p. 3265 (Lebel et al., 2016), is one such unexpected 
long-term effect. FCR has been documented in various cancer types (Hanprasertpong et 
al., 2017; Petzel et al., 2012; Thewes et al., 2013; van de Wal et al., 2016), regardless of 
illness prognosis (Hedman et al., 2017), and has been shown to persist over time 
(Mehnert et al., 2013; Savard & Ivers, 2013).  
Understanding the factors associated with FCR in YAs is a critical first step to 
developing appropriate services. Studies that have examined variables related to FCR in 
YAs have predominantly used sociodemographic and clinical cancer variables. Younger 
age is frequently associated with higher levels of FCR (Lebel, Tomei, et al., 2013; 
Mehnert et al., 2009; Shay et al., 2016; Simard et al., 2013; Thewes et al., 2013; van de 
Wal et al., 2016), but little research has examined whether the association between age 
and FCR differs within the YA age range of 15 to 39 years. Psychological distress has 
also been associated with higher levels of FCR (Simard et al., 2013). Distress is 
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particularly relevant, considering that YAs with cancer report higher distress levels than 
their peers without cancer, with differences persisting into later adulthood (Jorngarden et 
al., 2007; Seitz et al., 2010). Further, higher levels of anxiety have been associated with 
FCR in breast and cervical cancer survivors (Hanprasertpong et al., 2017; Lebel, Beattie, 
et al., 2013), which are among the most common types of cancers diagnosed in YA 
women.  
Beyond mental health, poor physical health, and increased severity of physical 
symptoms have been associated with greater FCR (Simard et al., 2013). Sleep 
disturbances are prevalent and persistent problems for cancer survivors (Ness et al., 
2013), and poor sleep quality has been associated with higher FCR (Berrett-Abebe et al., 
2015). Impaired body image as a result of cancer treatment is one of the most widespread 
negative impacts of cancer in young adulthood (Barnett et al., 2016; Bellizzi et al., 2012). 
YAs with cancer often feel or appear different than their peers (i.e., hair loss, scars, or 
changes in motor functioning), and these physical changes can increase distress and act as 
cancer reminders (D'Agostino & Edelstein, 2013; Epelman, 2013). Although these factors 
may be independently associated with higher levels of FCR, it is not yet known which, if 
any, contribute the most to FCR after adjusting for the impact of other significant factors.  
In addition to factors that are associated with higher FCR, it is equally possible 
that there are protective factors that could serve to buffer against FCR. For example, the 
theory of post-traumatic growth suggests that it is possible to move forward from a cancer 
diagnosis and treatment in healthy ways (Zebrack et al., 2015). Strong interpersonal 
relationships (Bellizzi et al., 2012; Eom et al., 2013), could also serve as protective 
factors against experiencing high levels of FCR. However, no research has examined the 
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relationships between FCR, post-traumatic growth, and social support in a YA sample, 
suggesting this is an essential area for further study. 
Establishing the prevalence of FCR in YAs has been hampered by measurement 
issues (Simard et al., 2013). Within the YA cancer population, a systematic review of 
FCR has suggested the prevalence of FCR ranges between 31% and 85% (Yang et al., 
2019). Using the Cancer Worry Scale, Thewes et al. found that in a sample of 73 YAs in 
the Netherlands, 62% experienced high levels of FCR (Thewes et al., 2018). Similarly, 
Sun and colleagues used the Fear of Progression Questionnaire-Short Form to measure 
FCR in a sample (n=249) of YAs in China. In their sample, 35.7% of patients reported 
dysfunctional levels of FCR (Sun et al., 2019). In the 2010 LIVESTRONG Survey, 85% 
of YAs with cancer (n=1,395) indicated yes on a single question about whether they 
worried about cancer coming back since completing treatment (Shay et al., 2016). While 
these results present preliminary information about the prevalence of FCR in YA cancer 
survivors, additional research is needed to clarify findings using a validated psychometric 
measure of FCR in a large, diverse sample of YAs.  
The purpose of this current study was to document the prevalence and examine 
factors associated with FCR in a heterogeneous sample of YAs with cancer. Exploring 





The current research uses data from the Young Adults with Cancer in their Prime 
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(YACPRIME) Study, the purpose of which was to provide a comprehensive picture of the 
needs of YAs with cancer in Canada. The YACPRIME study is a collaborative patient-
oriented research project conducted in partnership with Young Adult Cancer Canada 
(YACC), the leading support and advocacy organization devoted to YAs living with, 
through, and beyond cancer. Patient partners played a crucial role in identifying FCR as a 
priority topic of exploration for the YA population, as well as choosing additional 
variables to study, recruiting participants, reviewing, and contextualizing findings. YACC 
helped to recruit participants through direct emails, media promotion, online 
advertisements, and social media posts. The study officially opened in June 2017 and 
closed March 2018 and received ethics approval from Memorial University’s 
Interdisciplinary Committee on Ethics in Human Research (ICEHR). To be eligible to 
participate in the YACPRIME Study, YAs needed to have been diagnosed with cancer 
between the ages of 15-39, currently be 19 years of age or older to consent to participate 
and reside in Canada.  
Six hundred and twenty-two individuals completed the YACPRIME study, 
however, for the present study, we restricted the sample to those currently between the 
age of 19 and 39 (n=508), with an additional 47 excluded that did not respond to the 9 
items of the principal outcome measure, leaving a remaining sample size of 461. The 
mean age of the sample was 32.3 years (SD = 4.7). Participants were predominantly 
Caucasian (87%), female (87.6%), in committed relationships (67.5%), had between 14 
and 18 years of education (58.6%), and 34.1% reported having personal incomes of less 
than $20,000. The most commonly reported cancer diagnoses/categories included blood 
cancers (27.1%), breast cancer (25.2%) and female genitourinary cancers (11.1%). 
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Approximately one-third of participants were diagnosed with Stage II cancer, with a 
median time since diagnosis of 3.0 years. Table 1 provides descriptive characteristics for 
the entire sample. 
Table 1. Sociodemographic variables.  
 Frequency (%) 
 n = 461 
Age, Mean (SD) 32.3 (4.7) 
 < 26 Years  49 (10.6%) 
 26 – 30 Years 98 (21.3%) 
 31 – 35 Years 177 (38.4%) 
 36 – 39 Years 137 (29.7%) 
Age at Diagnosis   
 < 25 Years (Ref) 104 (22.6%) 
 25 – 29 Years 127 (27.5%) 
 30 – 33 Years 133 (28.9%) 
 34 – 39 Years 94 (20.4%) 
 Missing 3 (0.7%) 
Sex  
 Male 57 (12.4%) 
 Female 404 (87.6%) 
Race/Ethnicity  
 White 401 (87.0%) 
 Asian  17 (3.7%) 
 Multi-racial/Ethnic Identity 16 (3.5%) 
 Aboriginal/First Nations 13 (2.8%) 
 Other 14 (3.0%) 
Relationship Status  
 Single 150 (33.5%) 
 In a relationship 311 (67.5%) 
Children  
 No children 301 (65.3%) 
 1+ children 160 (34.7%) 
Education, Mean Years (SD) 17.0 (3.1) 
 < 14 Years 45 (9.8%) 
 14 – 18 Years 271 (58.6%) 
 19+ Years 132 (28.6%) 
 Missing 13 (2.8%) 
Income  
 Less than $20,000 157 (34.1%) 
 $20,000 to less than $40,000 107 (23.2%) 
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 $40,000 to less than $60,000 91 (19.7%) 
 $60,000 or more 105 (22.8%) 
 Missing 1  (0.2%) 
Cancer Diagnosis  
 Breast 116 (25.2%) 
 Female Genitourinary  47 (11.1%) 
 Male Genitourinary 5 (1.3%) 
 Thyroid 30 (8.5%) 
 Blood Cancers 125 (27.1%) 
 Head & Neck 40 (8.7%) 
 Gastrointestinal 41 (8.9%) 
 Skin 15 (3.3%) 
 Multiple Types 23 (5.0%) 
 Other 5 (1.1%) 
Cancer Stage  
 Stage 1 62 (13.4%) 
 Stage 2 138 (29.9%) 
 Stage 3 106 (23.0%) 
 Stage 4 65 (14.1%) 
 Don’t Know 59 (12.8%) 
 Not Applicable 31 (6.7%) 
Previous Recurrence  
 No 375 (81.3%) 
 Yes 86 (18.7%) 
Time Since Diagnosis, Median Years (M, SD) 
               Range 0-23 years 
3.0 (3.8, 3.8) 
 
Dependent Variable 
Fear of cancer recurrence was measured with the Fear of Cancer Recurrence 
Inventory-Short Form (FCRI-SF) (Simard & Savard, 2015), which is comprised of nine 
items used to measure the severity of FCR. Participants answer questions regarding the 
degree to which they are anxious cancer will return, as well as the amount of time spent 
worrying about recurrence (Simard & Savard, 2009). The initial validation of the measure 
suggested a proposed cutoff of 13+ (Simard & Savard, 2015); however more recent 
examination suggests that scores of < 16 are suggestive of minimal levels of FCR, scores 
of 16-21 are suggestive of problematic levels of FCR, and scores of 22+ indicate 
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clinically significant levels of FCR. These cutoff scores have demonstrated high 
sensitivity and adequate specificity (Fardell et al., 2018; Simard & Savard, 2015). 
Cronbach’s alpha was 0.85, demonstrating high internal consistency within this sample.  
Independent Variables  
Sociodemographic variables and cancer history: Sociodemographic variables, 
cancer history data, and a single item regarding perceived connection to, and 
identification with, the YA cancer community were collected by self-report.  
The Kessler Psychological Distress Scale (K10) was used to measure participants’ 
distress within the last month and assesses symptoms of anxiety and depression (Kessler 
et al., 2002). The K10 consists of 10 items; scores across items are summed with a 
minimum score of 10 (indicating no distress) and a maximum score of 50 (indicating 
severe distress).  Total scores ranging from 20-24 are suggestive of mild distress, scores 
from 25-29 are indicative of moderate distress, and scores ≥30 suggest severe distress 
(Andrews & Slade, 2001). The K10 has been successfully utilized with an adolescent and 
YA population (McCarthy et al., 2016). Cronbach’s alpha was 0.90 within the sample. 
The Short-Form Health Survey 12 (SF-12) Physical Component Summary (PCS) 
provided a measure of physical well-being and health-related quality-of-life and was used 
to complement mental health symptoms measured by the K10. Questions require 
participants to indicate functional limitations as a result of physical health in the last four 
weeks (Ware et al., 1996), and this measure has been used to assess physical functioning 
in adolescents and YAs with cancer (Wilder Smith et al., 2013). Participant responses are 
scaled to provide total scores ranging from 0-100, with a score of 50 indicating average 
health and a standard deviation of 10 (User’s manual for the SF-12v2 Health Survey 
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2012).  Scores ≥ 50 suggest good health, 40-49 as average health, 30-39 as poor health, 
and <30 as very poor health. Cronbach’s alpha was 0.53 within the sample. 
The Pittsburgh Sleep Quality Index (PSQI) was used to measure participants’ self-
reported sleep quality and potential sleep disturbances within the last month and includes 
19 items with higher scores indicating worse sleep quality (Buysse, 1989). A total cutoff 
score of > 5 has been shown to have adequate sensitivity and specificity in determining 
sleep dysfunction (Buysse, 1989), with sufficient construct validity, and has been used in 
an adolescent and YA population (Beck et al., 2004; Daniel et al., 2016). Cronbach’s 
alpha was 0.82 within the sample. 
The Post Traumatic Growth Inventory (PTGI) was used to evaluate personal 
growth, change in perspective, and adaption, and has been used to measure growth within 
a cancer population (Cordova, 2001; Holtmaat et al., 2017; Jansen et al., 2011; Tedeschi, 
1996). Scores on the PTGI were dichotomized to ease interpretation; total scores that had 
an average response of at least moderate (≥63) were categorized as moderate/high post-
traumatic growth, with remaining total scores (≤62) classified as no/minimal post-
traumatic growth (Jansen et al., 2011). Cronbach’s alpha was 0.94 within the sample. 
The Body Image Scale (BIS) was used to evaluate participants' body image 
dissatisfaction as a result of cancer and treatment, and are rated within the last week 
(Hopwood, 2001). There are no widely used clinical cutoffs for the BIS; however, Falk 
Dahl and colleagues used scores of ≥ 8 to signify higher body image dissatisfaction, and 
<8 to indicate lower body image dissatisfaction in women with breast cancer (Falk Dahl 
et al., 2010). Cronbach’s alpha was 0.92 within the sample. 
The Medical Outcome Study Social Support Survey (MOS-SSS) was used to 
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measure participants’ levels of perceived social support (Sherbourne & Stewart, 1991) 
and has been used in cancer and chronic illness populations (Priede et al., 2018).  The 
mean total of social support reported by Sherbourne and Stewart was used as an average 
level of social support in a chronic illness population (M = 70.1), and the standard 
deviation (SD = 24.2) was used to categorize responses as below-average (low) social 
support (≤ 45.9) and above-average (high) social support (≥94.3) (Sherbourne & Stewart, 
1991). Cronbach’s alpha was 0.95 within the sample. 
Statistical Analysis 
Descriptive statistics were used to characterize the sample’s demographic and 
clinical characteristics. Prevalence of clinical FCR was calculated using frequency data, 
comparing the proportion of participant scores that met or exceeded the cutoff of 22 in the 
total sample. The proportion of missing data was assessed to ensure the generalizability of 
the sample; the rate of missing data was low at 4.5% (Dong, 2013). Logistic regression 
uses complete case analysis and can provide asymptotically unbiased estimates under a 
wide range of missing-data assumptions (Bartlett et al., 2015). Univariate binomial 
logistic regression was used to examine associations between bio-psycho-social variables 
and clinical FCR (scores of ≥22 on the FCRI-SF (Fardell et al., 2018)) (Laerd Statistics, 
2017). Covariates with p values <.10 were then simultaneously entered into a multiple 
binomial logistic regression model (Bursac et al., 2008). Nagelkerke R2 was used to 
measure the amount of variance in FCR accounted for by the multivariate model 
(Nagelkerke, 1991). To evaluate the effectiveness of the predicted classification against 
the actual classification of clinical FCR in the multivariate model sensitivity, specificity, 
positive predictive value, and negative predictive value were used (Laerd Statistics, 
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2017). Analyses were conducted using SPSS Version 25. All tests were two-sided, with p 
< 0.05 indicating statistical significance. 
3.4 Results 
Approximately 84.4% of participants scored 16 or higher on the FCRI-SF, 
suggestive of maladaptive levels of FCR, with 59.2% of participants in the sample 
reporting scores equal to greater than 22, consistent with clinical levels of FCR. Using the 
initial proposed clinical cutoff of 13 or higher, 92.2% of the sample would meet or exceed 
this score. An examination of individual item responses indicated that participants 
reported the strongest endorsement for the item indicating it is reasonable to be worried 
about cancer, followed by being afraid that cancer will return, and thinking about 
recurrence triggering other unpleasant thoughts. Additionally, 16.2% (n=75) of 
participants reported spending a few or several hours a day preoccupied with thinking 
about the possibility of recurrence. Refer to Table 2 for complete descriptive data for the 
other psychological variables of interest. 
Table 2. Psychometric measures descriptives.   
 Measure 
Range 
Mean (SD) Frequency % 
Fear of Cancer Recurrence 
Inventory – Short Form 
0-36 22.8 (6.9)  
Kessler Psychological Distress Scale 10-50 25.1 (7.8)  
No distress (<20)   26.3% 
Mild distress (20-24)   24.5% 
Moderate distress (25-29)   20.8% 
Severe distress (30+)   28.4% 
SF12: Physical Component 
Summary 
0-100 43.0 (9.5)  
Good (50+)    31.4% 
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Average (40-49)    31.7% 
Poor (30-39)   29.6% 
Very Poor (< 30)   7.3% 
Pittsburg Sleep Quality Index 0-21 9.1 (3.9)  
Good Sleep (≤5)   19.0% 
Poor Sleep (>5)    81.0% 
Post Traumatic Growth Inventory 0-105 56.2 (22.1)  
Moderate/High PTG (63+)   41.4% 
Minimal PTG (21-62)   58.5% 
Body Image Scale 0-30 14.3 (8.6)  
Not dissatisfied (<8)   27.5% 
Dissatisfied (8+)   72.5% 
MOS-Social Support Survey 0-100 66.9 (21.6)  
High (94.3+)    10.4% 
Average (45.9-<94.3)   71.9% 
Poor (<45.9)   17.7% 
 
Separate univariate binomial logistic regression models were used to identify 
significant independent factors associated with clinical FCR. For a complete list of 
demographic, medical, and psychometric variables, consult Table 3. At the univariate 
level, participants reporting five or more years since diagnosis were significantly less 
likely to experience clinical levels of FCR (Odds Ratio [OR] = 0.423 [0.263, 0.682], p = 
<.0005), when compared to participants with a diagnosis less than two years ago. 
Alternatively, having a previous recurrence meant participants were more likely to 
experience clinical levels of FCR (OR = 2.678 [1.561, 4.596], p <.0005). Several 
demographic factors were independently associated with higher levels of FCR, including 
older age at diagnosis, female sex, and having children. Level of distress was significantly 
associated with clinical FCR regardless of severity (Mild distress: OR = 2.292 [1.351, 
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3.891], p = .002, Moderate distress: OR = 5.452 [3.027, 9.818], p < .0005, Severe 
distress: OR = 7.449 [4.239, 13.092], p < .0005); as was poor sleep and body image 
dissatisfaction. Individuals who reported not feeling connected to the YA cancer 
community were significantly more likely to experience clinical FCR (OR = 1.623 
[1.035, 2.546], p = .035). Variables not independently related to the likelihood of 
experiencing FCR included: current age, relationship status, years of education, income, 
cancer stage, physical health, post-traumatic growth, and social support.  
A multivariate binomial logistic regression was conducted with all significant 
independent variables entered simultaneously. The logistic regression model was 
statistically significant, χ2(14) = 116.427, p < .0005, and these predictors explained 36.2% 
of the variance (Nagelkerke R2) in clinical FCR. The multivariate model correctly 
classified 74.0% of cases; sensitivity was 83.3%, and specificity was 60.3%, while the 
positive predictive and negative predictive values were 75.5% and 71.1%, respectively. In 
the multivariate model, time since diagnosis of five or more years continued to be 
associated with lower levels of FCR (Adjusted Odds Ratio [AOR] = 0.354 [0.175, 0.781], 
p = .004). Individuals who identified previously experiencing a recurrence (AOR = 3.468 
[1.630, 7.379], p = .001) were more likely to experience clinical FCR. Participants with 
mild, moderate, and severe psychological distress were more than 2.9 (AOR = 2.947 
[1.457, 5.961], p = .003), 5.6 (AOR = 5.632 [2.365, 12.039], p = <.0005), and 8.9 (AOR 
= 8.977 [4.047, 19.472], p = <.0005) times more likely to experience clinical FCR than 
participants without distress. Experiencing body image dissatisfaction as a result of 
cancer (AOR = 2.311 [1.300, 4.107], p =.004) remained significantly related to an 
increased likelihood of clinical FCR. At the multivariate level, after adjusting for 
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covariates, age at diagnosis, parental status, sleep disturbance, and connection to the YA 
cancer community were no longer significantly associated with FCR. 
Table 3. Factors associated with clinical levels of FCR. 
 Univariate Logistic Regression Analysis 
 
Multivariate Logistic Regression 
Analysis 
 
Odds Ratio [95%CI] P 
Adjusted Odds Ratio 
[95%CI] P 
    <.0005* 
Age  .183†   
< 26 Years (Ref) 1    
26 – 30 Years 0.716 [0.356, 1.439] .348   
31 – 35 Years 1.175 [0.612, 2.256] .629   
36 – 39 Years 0.789 [0.405, 1.536] .486   
Age of diagnosis  .012†   
< 25 Years (Ref) 1  1  
25 – 29 Years 1.414 [0.840, 2.380] .192 0.807 [0.391, 1.669] .563 
30 – 33 Years 2.340 [1.376, 3.978] .002 1.272 [0.557, 2.904] .568 
34 – 39 Years 1.821 [1.031, 3.213] .039 0.998 [0.410, 2.427] .997 
Sex     
Male (Ref) 1  1  
Female 2.400 [1.363, 4.226] .002 2.172 [0.995, 4.739] .051 
Relationship status     
Single (Ref) 1    
In a relationship 1.169 [0.787, 1.735] .439   
Children     
No children (Ref) 1  1  
1+ children 1.511 [1.015, 2.250] .042 1.313 [0.741, 2.326] .351 
Education  .529†   
< 14 years (Ref) 1    
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14 – 18 years 0.820 [0.425, 1.582] .554   
19+ years 0.704 [0.349, 1.418] .326   
Income  .272†   
< $20,000 (Ref) 1    
$20,000 to < $40,000 0.669 [0.404, 1.108] .119   
$40,000 to < $60,000 0.668 [0.394, 1.134] .136   
$60,000 or more 0.672 [0.405, 1.116] .125   
Cancer Stage  .364†   
Stage 1 (Ref) 1    
Stage 2 0.856 [0.459, 1.594] .728   
Stage 3 0.908 [0.473, 1.742] .604   
Stage 4 0.727 [0.355, 1.486] .155   
Don’t Know 0.698 [0.336, 1.450] .292   
Not Applicable 0.397 [0.164, 0.960] .051   
Time Since Diagnosis  <.0005†   
< 2 years (Ref) 1  1  
2 – 4 years 1.163 [0.733, 1.847] .521 1.448 [0.788, 2.661] .233 
 5+ years 0.423 [0.263, 0.682] <.0005 0.354 [0.175, 0.781] .004 
Previous Recurrence     
No (Ref) 1  1  
Yes 2.678 [1.561, 4.596] <.0005 3.468 [1.630, 7.379] .001 
Psychological Distress (K10)  <.0005†   
No distress (<20) (Ref) 1  1  
Mild distress (20-24) 2.292 [1.351, 3.891]  .002 2.947 [1.457, 5.961] .003 
Moderate distress (25-29) 5.452 [3.027, 9.818] < .0005 5.632 [2.365, 12.039] <.0005 
Severe distress (30+) 7.449 [4.239, 13.092] < .0005 8.877 [4.047, 19.472] <.0005 
Physical Component Summary (SF-12 - PCS) .810†   
Good (50+) (Ref)  1    
Average (40-49)  1.083 [-0.655, 1.789] .757   
Poor (30-39) 1.284 [0.766, 2.151] .343   
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Very Poor (< 30) 1.043 [0.459, 2.367] .920   
Pittsburgh Sleep Quality Index (PSQI)    
Good Sleep (≤5) (Ref) 1  1  
Poor Sleep (>5)  1.786 [1.104, 2.890] .018† 0.730 [0.367, 1.450] .368 
Post Traumatic Growth (PTGI)    
Moderate/High PTG (63+) 
(Ref) 
1    
Minimal PTG (21-62) 0.976 [0.669, 1.424] .901   
Body Image Dissatisfaction (BIS)     
Not dissatisfied (<8) (Ref) 1  1  
Dissatisfied (8+) 4.180 [2.684, 6.510] <.0005 2.311 [1.300, 4.107] .004 
Social Support (MOS-SSS)  .224†   
High (94.3+) (Ref) 1    
Average (45.9-<94.3) 1.225 [0.654, 2.294] .526   
Poor (<45.9) 1.820 [0.855, 3.874] .120   
Connection to YA Cancer Community     
Connected (Ref) 1  1  
Not connected 1.623 [1.035, 2.546] .035 1.454 [0.814, 2.599] .206 
† Overall significance for variables with more than two categories at the univariate level. 
 
* Significance for the overall multivariate model. 
 
Continuous variables were categorized based on available data, or population distribution 
within the sample. 
 
3.5 Discussion 
The goal of the present study was to determine the prevalence of, and factors 
associated with, FCR in a diverse sample of YA cancer survivors. We found that 84% of 
our sample of 461 YAs with cancer experienced problematic levels of FCR (score ≥ 16) 
and 59% met or exceeded the cutoff of 22 to identify clinically significant levels of FCR 
(Fardell et al., 2018). Using the initial cutoff of 13 or more proposed in the validation of 
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the measure (Simard & Savard, 2015), 92% of the sample would be considered to have 
evidence of FCR. The most appropriate clinical cutoffs for the YA age group have not 
been determined; however, the level of clinically significant FCR in our study falls within 
the range of prevalence rates previously reported in the literature, both in the general 
cancer population (Simard et al., 2013) and in YAs particularly (Thewes et al., 2018). 
Demographic and Clinical Correlates of FCR in YA cancer survivors 
Current age within the YA sample was not significantly related to higher levels of 
FCR, nor was the age at which cancer was diagnosed. This important finding suggests 
that FCR impacts YAs across this age range as opposed to younger age more generally. 
Cancer stage was not a significant predictor of clinical FCR in our study, which suggests 
that fear is not directly related to prognosis and might be more of a subjective assessment 
of the impact of cancer (Crist & Grunfeld, 2013; Hedman et al., 2017; Koch et al., 2013; 
Savard & Ivers, 2013). Similarly, poorer physical health was not a significant predictor of 
experiencing clinical FCR.  
Participants who were more than five years out from their cancer diagnosis were 
significantly less likely to experience clinical FCR than participants who reported having 
cancer for less than two years. The 5-year relative survival rate is a standard metric for 
measuring illness prognosis and response to treatment (Understanding Statistics Used to 
Guide Prognosis and Evaluate Treatment, 2016). Increased cancer duration may provide 
patients with greater exposure to cancer-related knowledge and expertise, which helps to 
reduce FCR over time (Lichtenthal et al., 2017). Alternatively, having experienced a 
cancer recurrence was associated with 3.5 times the likelihood of experiencing FCR. 
Individuals who have had a recurrence may be more likely to perceive symptoms, 
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physical changes or health information, as a greater threat to their health and well-being 
and consequently experience higher FCR (Fardell et al., 2016; Rippetoe, 1987).  
Psychological Correlates of FCR in YA cancer survivors 
Participants who reported any degree of psychological distress were more likely to 
experience clinical FCR than individuals without distress. Anxiety has been reported to 
mediate the relationship between age and FCR (Lebel, Beattie, et al., 2013), and there is 
evidence supporting the interaction between FCR and pathological cognitive processes, 
like rumination (Liu et al., 2018), which is apparent in anxiety and depressive disorders 
(Nolen-Hoeksema, 2000). These underlying factors hint at the relationship between these 
constructs; however, the direction and nature of the relationship between pre-existing 
depression and anxiety symptoms with FCR requires further exploration. The present 
study is the first to demonstrate an association of body image dissatisfaction with FCR. 
Participants with greater body image dissatisfaction were 2.5 times more likely to 
experience clinical FCR than participants with less body image dissatisfaction. Physical 
changes to body image can serve as reminders of the substantial impact that treatment has 
had on the individual (D'Agostino & Edelstein, 2013), and possibly compound fears 
surrounding recurrence. Sleep disturbance, levels of post-traumatic growth, social 
support, and feelings of connection to other YAs with cancer were not related to FCR.  
Implications for Treatment of FCR in YA cancer survivors 
Our findings support past research suggesting that patients are more likely to 
experience elevated levels of FCR in the early stages of diagnosis and treatment 
(Humphris, 2003; Savard & Ivers, 2013) and after experiencing a recurrence. Clinicians 
working with YAs with cancer should consider providing interventions during the early 
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phases of treatment and after subsequent health challenges to address the impact of FCR 
more effectively. Exposure therapies could be used to help patients manage fear in 
response to emotionally evocative stimuli (Simonelli et al., 2017), and the cognitive 
features of FCR indicate YAs may benefit from cognitive behavioural therapy (CBT) and 
acceptance-based approaches (Mutsaers et al., 2016). Our findings suggest that 
incorporating body image content into FCR interventions and focusing on those 
individuals who have experienced a recurrence already may allow for personalized 
treatment by targeting concerns that may contribute to their fears. 
Limitations 
The study utilized a cross-sectional design, which does not allow us to determine 
the direction of the observed associations. Men and racial and ethnic minorities were 
under-represented, which impacts the generalizability of our findings to the larger YA 
population. Lastly, medical information was collected using self-report, and data has the 
potential to reflect inaccuracies.  
Conclusions  
The majority of YAs diagnosed with cancer experience clinically significant 
levels of FCR. The findings of this study can be used to refine the identification of 
individuals who are at risk of experiencing severe levels of FCR: including YAs with a 
more recent cancer diagnosis, those who have experienced recurrence, those with body-
image dissatisfaction, and those with higher levels of psychological distress. By targeting 
and tailoring interventions, healthcare providers will be better equipped to meet the 


















4.1 Summary of Main Findings 
This body of work utilized national, cross-sectional data to examine the 
psychological consequences of cancer for YAs in Canada. The first study investigated 
cancer's contribution to the psychological distress of YAs by comparing them to age, sex, 
and education matched peers. YAs with cancer, on average, reported moderate levels of 
distress, significantly greater than the subclinical levels reported by matched peers. These 
findings are consistent with other studies that have used healthy comparison samples. 
Compared to matched peers, YAs with cancer reported poorer perceived health quality 
and were more likely to report being in a relationship, be unattached and living with 
others, living with parents, and have an annual income of less than $40,000. This study 
also identified that not working, body image dissatisfaction, poor social support, and 
maladaptive and clinical levels of FCR were associated with high distress in YAs with 
cancer. YAs with cancer were more likely to report impaired mental and physical health, 
and be finically disadvantaged, illustrating increased vulnerability for impaired global 
well-being than other individuals experiencing comparable developmental stressors. 
Additionally, diverse factors, including financial, social and emotional resources, enhance 
YAs with cancer’s risk and require holistic psychosocial support to assist them with 
coping with the long-term impacts of cancer. 
The second study in this investigation examined the prevalence of, and factors 
associated with, FCR using the same sample of YA cancer survivors described above. 
Maladaptive FCR was reported by 84% of YAs with cancer in the sample, and 59% met 
or exceeded the cutoff for clinically significant FCR. Having a cancer recurrence, mild, 
moderate and severe levels of psychological distress and body image dissatisfaction were 
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associated with an increased likelihood of experiencing clinical levels of FCR. Having a 
time since diagnosis of five years or more was associated with a decreased likelihood of 
experiencing clinical FCR. Clinical levels of FCR represent an ubiquitous psychological 
challenge for YAs with cancer and early identification in patients with a recurrence 
history, distress, or impaired body image can assist with pinpointing patients who may 
benefit from psychological interventions.  
4.2 Implications 
There is a global acceptance that cancer impacts a patient's mental and physical 
health, requiring psychosocial care alongside physical cancer treatment. The studies 
outlined in this investigation provide essential contributions to our collective 
understanding of psychological health and well-being for YAs with cancer, increasing our 
ability to identify particularly vulnerable individuals. This section will review a growing 
body of literature examining psychosocial interventions to provide possible solutions to 
address the specific needs of YAs with cancer in Canada. 
A meta-analysis and systematic review conducted by Richter et al. examined the 
impact of psychosocial interventions on the mental health of YAs compared to control 
participants on domains of well-being, cancer knowledge and psychological distress 
(Richter et al., 2015). Twelve studies met inclusion criteria that contained interventions 
facilitated with technology, psychoeducation, physical exercise, or that combined several 
elements, including peer support, individual work with a healthcare practitioner, and 
elements of the other intervention types. The review revealed some enhanced outcomes 
for patients compared to control participants and subjective improvements; however, 
when results across studies were pooled, improvements for participants receiving 
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interventions disappeared, suggesting significant limitations in current psychosocial 
services. Moreover, Walker and colleagues reviewed psychosocial interventions for 
patients diagnosed in early young adulthood and found that nine of the 11 included 
studies yielded benefits across diverse well-being outcomes (Walker et al., 2016). The 
limited studies which included YAs found improvements in measures of anxiety and 
quality-of-life for YAs not receiving treatment, but no difference in YAs currently 
undergoing treatment. Osborn and colleagues reported short-term and long-term benefits 
of CBT for anxiety, depression and quality-of-life for adult cancer survivors (Osborn et 
al., 2006). Together these conflicting studies suggest that to be more effective, YAs may 
require interventions tailored to their needs, reflecting the intersection of their cancer care 
and developmental requirements.   
To better understand the intervention preferences of YAs, Rabin and colleagues 
interviewed 20 YA patients individually, having them assess the helpfulness of varied 
intervention types and their delivery preferences (Rabin et al., 2013). Participants 
reported that effective and helpful interventions needed to accommodate the demands 
associated with their various academic, professional and social roles, noting it can add 
pressure to incorporate behavioural interventions into their busy lives. One YA 
participant noted that flexibility in attendance and less frequent scheduling would address 
these competing needs. A similar need for balance was identified in the value of in-person 
interventions and carving out the time needed to attend them. The convenience of 
intervention delivery was also a key theme identified by participants, and many suggested 
that web-based or remote services would increase patients' ability to engage in services. 
Finally, social support, either available through online platforms and social media, or 
 74 
connecting with others, was identified as an essential component for YAs. In the present 
investigation, poor social support increased the likelihood of experiencing high distress, 
suggesting a desire for social support may be an attempt to address psychological 
responses to cancer. 
An integrative review conducted by Thorton et al. examined studies (n=17) of 
psychosocial interventions for YAs with cancer to determine thematic elements 
associated with successful intervention outcomes for this population (Thornton et al., 
2020). Similarly, engaging with technology in interventions and peer support were 
reported as essential themes for effective YA interventions. Utilizing creative expression, 
accessing individual support, encouraging participants to engage in physical activity and 
developing relationships and establishing supportive communication with clinicians were 
also identified as characteristics helping tailor interventions for YAs with cancer. YAs are 
rarely represented as a unique population in intervention research. Understanding the 
qualities that increase the success and application of theoretical research for YAs with 
cancer is crucial for adapting existing interventions to reflect this population's competing 
needs. 
Psychoeducational interventions that provide patients with disease-specific 
information to assist them in addressing treatment-related concerns have successfully 
addressed mental health symptoms, fostering resilience and building self-efficacy (Dastan 
& Buzlu, 2012; Matsuda et al., 2014; Wu et al., 2018). Addressing YAs' preference for 
timely interventions, researchers have begun exploring delivering psychoeducational 
interventions using smartphones for addressing FCR (Akechi et al., 2018) and web-based 
self-help to manage fertility-related distress (Lampic et al., 2019). These studies offer 
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promising intervention designs providing convenient and tailored ways for YAs to 
manage distress and FCR.  
To address overall health-related quality-of-life, Aubin et al. created a CBT 
intervention designed for YAs with cancer (Aubin et al., 2019). Participants (n=119) were 
randomly assigned to receive the three-session interventions delivered in-person or over 
Skype, based on individual choice, or the control condition. Participants were assessed at 
baseline, post-intervention three-month follow-up. Only participants completing the 
intervention condition reported significant improvements in mental health symptoms, 
emotional well-being and quality-of-life. Further, there were no significant differences in 
YA outcomes between participants receiving face-to-face or Skype intervention delivery. 
The brief design of this intervention helps address YA patient's preference for 
convenience and may be particularly beneficial for individuals who cannot commit to 
longer-term interventions. This design also offers individual support, a characteristic of 
successful past YA interventions. Giving participants the ability to select their 
intervention format may also account for positive outcomes and the lack of significant 
outcome differences for participants completing the intervention. Consequently, the 
opportunity to customize services may enhance outcomes for YA patients, and the impact 
of increased intervention choice warrants further exploration. 
Mindfulness-based interventions have also been explored to address mental health 
symptoms and quality of life for YAs with cancer in Canada. Nissim and colleagues 
developed a mindfulness-based cognitive group therapy for YAs with varied cancer 
diagnoses (Nissim et al., 2020). Seventy-seven YAs participated in an eight-week 
program, including meditation, yoga, experiential practices, psychoeducation, group 
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support and completed a battery of psychometric measures assessing anxiety, depression, 
quality-of-life, stress and compassion. The intervention was deemed acceptable to 
participants based on engagement and attendance, and significant benefits were reported 
across assessment measures. A small portion of participants completed follow-up 
interviews and noted additional benefits of increased ability to accept their emotions, 
build a sense of belonging, address body dissatisfaction and FCR. Multifaceted 
mindfulness-based interventions offer promising outcomes for addressing mental health 
symptoms generally and FCR and body image concerns, which the current investigation 
has highlighted as an essential risk factor for global distress and clinical levels of FCR.  
A comparable study conducted by van de Gucht and colleagues developed a 
mindfulness-based intervention for YAs (n=16) post-cancer treatment (Van der Gucht et 
al., 2017). Participants were assessed twice before the intervention, after completing the 
eight-week group and at a three-month follow-up on measures assessing the quality-of-
life and emotional distress. Participants demonstrated significant increases in quality-of-
life and decreases in emotional distress between baseline and post-intervention and three-
month follow-up. Changes in FCR was not independently noted; however, FCR was 
significantly negatively correlated to quality-of-life, providing further evidence that FCR 
may be treated with mindfulness interventions. Additionally, both mindfulness programs 
were offered in a group format, catering to YAs preference for interventions with social 
support and accountability (Rabin et al., 2013), illustrating promise for their ability to 
address the unique psychosocial needs of YAs with cancer. 
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Existing research has seldom examined interventions specifically designed to 
target psychological distress. Seciniti et al. conducted a meta-analysis to explore the 
relationship between cancer acceptance and psychological distress in adults with cancer 
(Secinti et al., 2019). Using pooled data from 78 studies, authors examined the 
relationships between cancer acceptance and general distress, cancer-specific distress, 
depression and anxiety symptoms; significant, negative effect sizes were found for all 
relationships. These findings illustrate the possible benefits of increasing cancer 
acceptance on reducing distress, suggesting that therapeutic modalities like Acceptance 
and Commitment Therapy (ACT) (Ost, 2014) could directly address global, psychological 
distress and cancer-specific distress. Exploring how cancer acceptance could address the 
high prevalence rates of distress among YAs with cancer represents an important future 
research area. Researchers have begun to develop ACT-based programs and protocols for 
adolescents and YAs with cancer; initial findings revealed three-day ACT group program 
to be both feasible and acceptable based on patient feedback, further illustrating the 
possible gains for this population(Clarke et al., 2020). 
There has been growing interest in the development of interventions created to 
address FCR specifically. In a systematic review and meta-analysis, Taube et al. 
examined the effect of psychological interventions on FCR in adults with cancer (Tauber 
et al., 2019). Thirty-two randomized controlled trials and open trials were included in the 
analyses, and overall there was a significant small effect of psychological interventions in 
addressing FCR post-intervention and maintained for analyses measuring later follow-up. 
Interventions that focused on cognitive processes (i.e., worry, rumination) instead of the 
content of thoughts yielded significantly larger effect sizes than interventions using 
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traditional CBT. Greater benefits were also noted for group-based interventions compared 
to individually administered interventions. Sharpe and colleagues sought to examine 
mediating and moderating factors that improved outcomes in a specialized intervention, 
ConquerFear, created with ACT principles to treat clinical FCR (Sharpe et al., 2019). 
Participants (n=150) completed the five-session program and were assessed at three time 
points; pre- and post-intervention, and at a six-month follow-up. Participants with the 
highest initial levels of clinical FCR showed greater improvements than participants in 
the relaxation, control group intervention. Mediation analysis revealed that changes in 
assessments of worry and intrusive thoughts partially mediated the relationship between 
treatment condition and FCR. These studies collectively provide compelling evidence for 
the use of psychological interventions that provide patients with ways to cope or change 
their engagement with thinking patterns that can address FCR. However, both studies 
utilized diverse adult samples, limiting the ability to draw conclusions for YAs with 
cancer.  
4.3 Strengths 
The population examination facilitated by both studies utilized a national dataset 
to capture the diverse experiences of YAs with cancer beyond provincial healthcare 
differences. Within the YA population in the United States, Kaul and colleagues are 
among the first to compare psychological distress differences, specifically between YAs 
with cancer and their non-cancer peers, using a large, representative national sample 
(Kaul et al., 2017). Young adults in North America share some cultural similarities; 
however, national differences in healthcare pose significant challenges in comparing 
health outcomes across countries (Lau et al., 2014).  
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There has been limited Canadian research on distress in YAs with cancer. Lang 
and colleagues used data from the Canadian Community Health Survey to compare 
perceived health and prevalence of mental illness between YA cancer survivors, YAs 
without cancer, older adult cancer survivors, and older adults without cancer (Lang et al., 
2018). Respondents provided an overall measure of self-perceived health and mental 
health on Likert scales, ranging from excellent to poor and yes/no responses to a 
healthcare professional diagnosed with a mood or anxiety disorder. Unfortunately, this 
study was limited by estimating the prevalence of mental health concerns using previous 
mental health diagnoses and perceived mental health with a single item. The first study 
expands on YA findings illustrated by Lang et al.(2018)  by using a validated measure to 
assess mental health symptoms within the last month (Andrews & Slade, 2001), as 
opposed to an estimate of the prevalence of mental health concerns by measuring 
previous mental health diagnoses and perceived mental health with a single-item. Using 
the K10 reduces the likelihood of having participants report past mental health diagnoses 
that do not necessarily provide a clear indication of current mental health functioning.  
 The second study provides the first estimate of FCR within a Canadian sample 
(Yang et al., 2017). The use of the FCRI-SF provides a reliable measurement of FCR 
within this population, where many existing studies have utilized single-item or study-
specific questions (Yang et al., 2017). In addition to the studies' nuanced findings in this 
investigation, this is the first study to examine the relationship between body image and 
FCR. Body image is integral in self-esteem and identity for YAs generally (Tiggemann, 
2004), and YAs with cancer often have body image concerns as a result of cancer 
(Barnett et al., 2016; Bellizzi et al., 2012), which can have clinical, psychosocial 
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implications for survivors (Zucchetti et al., 2017). This study provides important 
theoretical support for this relationship, necessary to effectively identify YAs with 
clinical FCR as well as provide insights into possible contributing factors for individuals 
in this population.   
Another strength of the studies is the inclusion of YAs survivors with diverse 
cancer diagnoses. Studies that have previously examined psychological distress and FCR 
within YAs with cancer have utilized narrow samples, mainly focusing on precise 
diagnoses (Hall et al., 2016; Kim et al., 2017; Naik et al., 2020), or excluding participants 
based on clinical characteristics (Kaul et al., 2017; Lang et al., 2015; Lang et al., 2018). 
Given the significant stressors and mental health vulnerabilities shared across the YA 
cancer population, it is much more meaningful to include YAs across different diagnoses 
than older survivors of the same diagnosis (Naik et al., 2020; Shay et al., 2016; Smrke et 
al., 2020). 
Finally, utilizing a POR approach, wherein YAs with cancer determined the 
studies’ objectives and participated in the dissemination of findings, ensures the results 
will be communicated in a way that is relevant and important to the wider patient 
population. Creating POR has also enhanced the translation of findings, by supporting the 
individuals directly involved in the projects with communicating results to wider patient 
networks to ensure clear messaging and decreasing the time taken for patients to access 
information. 
4.4 Challenges and Limitations 
The data collected by the YACPRIME study reflected national population 
distribution (Statistics Canada, 2020), but the most significant limitations of the studies 
 81 
included in this investigation relate to challenges associated with capturing the diverse 
demographic features of YAs with cancer in Canada. Participants were predominantly 
female sex, despite substantial effort dedicated to enhancing male participants' 
recruitment through targeted digital advertisements, snowball recruitment through male 
survivors, and including male survivors in promotional material. Similar recruitment  
rates of male participants have been demonstrated in health research (Maher et al., 2014), 
illustrating further investigation is needed to address this limitation more broadly (Ryan et 
al., 2019). Existing research reports sex differences in psychological distress (Burgoyne et 
al., 2015; Koyama et al., 2016; Wang et al., 2014) and FCR (Shay et al., 2016; Simard et 
al., 2013; Wang et al., 2015) for YAs with cancer; however, we did not find significant 
differences between female and male scores for total distress or FCR. Regardless, male 
participants' limited representation may not represent the true diversity in psychological 
responses to cancer.  
Representation from diverse races, ethnicities, and genders was also limited, as 
only roughly 12% of participants in each study identified as non-White. Matching 
participants on age, sex and education required excluding an additional nine participants 
as there were not enough comparable non-cancer peers; therefore, with limited participant 
diversity we did not use race or ethnicity as a fourth matching variable. Black, 
Indigenous, and people of colour experience a greater relative risk of being diagnosed 
with cancer (Mazereeuw et al., 2018; Moore et al., 2015). However, research has 
illustrated that participants with varied racial and ethnic identities do not have the same 
health outcome as white patients with cancer (Dixon et al., 2019; Esnaola & Ford, 2012). 
For example, Canadian census data for Indigenous and non-Indigenous Canadians found 
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that indigenous patients reported lower five-year survival than matched peers, consistent 
across 14 of the most common diagnoses (Withrow et al., 2017). In the United States, 
Black patients were less likely to receive chemotherapy to treat pancreatic cancer than 
white patients (Wright et al., 2020). Outcome differences are due to systemic healthcare 
barriers to accessing treatment that non-white patients with cancer face (Esnaola & Ford, 
2012; Horrill et al., 2019). Inability to effectively capture the needs of YAs with cancer of 
varied ethnicities and races further compounds the inequality of adequate supports. 
Participants within this sample were also older, with a mean age of 32 across both studies. 
YAs share the same developmental concerns, but how these manifest by age groups 
within this population may be very different. For example, younger YAs may be 
increasingly concerned about educational training and establishing their careers, while 
older YAs may be concerned with disruptions and maintaining their careers. Different 
reactions to stressors across this population limits the discussion of age-related nuances 
for YAs.  
Elements of the studies' methodology also limited this investigation. The data 
collection was cross-sectional, restricting the ability to infer the direction of relationships 
observed and the stability of these associations over time. Another methodological 
limitation was that these studies also relied on self-report data for cancer history and 
psychosocial variables. Self-report data can be prone to many individual biases and may 
increase the risk of inaccurate measurement of variables due to limited accuracy in recall, 
impaired self-awareness, and motivation when completing measures (Rosenman et al., 
2011); however, a study by Short and colleagues found participants self-report was 
comparable to administrative records for health utilization data (Short et al., 2009). This 
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provides reassurance that estimates included in the study are likely to reflect accurate 
health and symptom data. 
The methodology of this study was also limited by the use of convenience 
sampling for YAs with cancer. Critique of convenience sampling emphasizes that this 
sampling strategy has inherent bias and fails to represent the actual characteristics of the 
population of the study. Within the investigation, this strategy may have contributed to 
the unequal representation of males and diverse patient groups.  The possibility of 
inaccurately presenting the population's concerns is a particular limitation for Study 1, 
which compares the convenience sampling data for YAs with cancer to the systematically 
sampled data for non-cancer peers. Different sample strategies may have compounded the 
substantial population differences in distress reported by the study. However, research 
comparing outcomes across conveniently sampled and probability sampled participants 
with diabetes reported comparable results across samples (Bujang et al., 2012), 
suggesting that this strategy is still acceptable for estimating a population's experiences. 
Therefore, this limitation does not likely account for the significant discrepancies between 
this study's samples, supporting meaningful clinical population differences.  
Additionally, it is unlikely this difference in scores could also be compounded by 
the five-year discrepancy in data collection between the CCHS and YACPRIME samples. 
National consistency in prevalence of Canadian mental health concerns over this period 
(Chiu et al., 2020) and similar discrepancies in peer comparison research with data 
collected in the same period (Lang et al., 2018) further support our findings.  
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4.5 Future Directions 
 To acknowledge limitations of the present studies and the existing body of 
literature, several future directions for research are suggested. POR’s ability to enhance 
the quality and applicability of findings offers important benefits for future research for 
YAs with cancer. Including patients as future investigators for psychosocial programs 
would likely address the mixed findings regarding intervention effectiveness, and the 
consensus regarding tailoring program content and delivery to meet YA specific needs. 
POR has the added benefit of supported KT of research findings by supporting patient 
partners in sharing findings within larger patient networks.  
 Participants endorsement of worry and preoccupation associated with distress and 
FCR represents important cognitive targets for effective interventions for YAs. These 
concerns are consistent with cognitive behavioural conceptualization of cancer-related 
concerns for YAs (Hagstrom et al., 2020). Consequently, future studies exploring the 
provision of third-wave cognitive behavioural interventions that support acceptance and 
distress tolerance would offer important clinical insights in improving psychological 
outcomes for YAs with cancer. Based on investigation outcomes, and YA preference for 
interventions it would also be beneficial to further explore the nuances of social support's 
impact on distress, examining outcome improvements for services that are provided in 
individual and group-based formats. 
 Across both studies, body image dissatisfaction was the only consistent significant 
predictor of high distress and clinical FCR. Exploration of the relationships between these 
variables would further clarify psychological health concerns for patients and assist with 
developing psychosocial treatment goals for YAs with cancer. 
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4.6 Conclusions 
This investigation provides important insights into the prevalence of distress and 
FCR for YAs with cancer in Canada. Young adulthood represents a difficult 
developmental period and increased likelihood of experiencing mental health symptoms; 
compared to peers matched on age, sex, and education, YAs with cancer had significantly 
greater psychological distress. Greater years of education were associated with decreased 
distress, while not being employed, body image satisfaction, poor social support and 
elevated FCR were associated with an increased likelihood of distress. Being diagnosed 
with cancer five or more years ago was associated with a decreased likelihood of clinical 
FCR. Having a previous recurrence, clinical levels of psychological distress and body 
image dissatisfaction were associated with an increased likelihood of clinical FCR. 
Psychological distress and FCR represent important psychological side effects for YAs, 
and efforts to determine the relationship between these variables are essential for future 
psychosocial care for this population. 
Given the high prevalence rates of psychological responses to cancer for this 
population, health practitioners must prioritize identifying vulnerable YAs. To adequately 
address the substantial psychosocial support needs of YAs with cancer, it is necessary to 
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Appendix D. Fear of Cancer Recurrence Inventory – Short Form.
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Appendix I. Medical Outcome Survey – Social Support Survey.  
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